This appendix shows the list of included studies for the review. We have indicated which Key Question it is included for at the end of the citation with the record ID.

1.

Abbasi SH, Heidari S, Mohammadi MR, et al. Acetyl-L-carnitine as an adjunctive therapy in the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a placebo-controlled trial. Child Psychiatry Hum Dev. 2011 Jun;42(3):367–75. doi: 10.1007/s10578-011-0220-y. PMID: 21336630. IncludeDE_KQ2 Record ID 17191 [PubMed: 21336630] [CrossRef]

2.

AbbVie, AbbVie. Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD). 2008. IncludeDE_KQ2 Record ID 13767

3.

Abikoff H, Gallagher R, Wells KC, et al. Remediating organizational functioning in children with ADHD: immediate and long-term effects from a randomized controlled trial. J Consult Clin Psychol. 2013 Feb;81(1):113–28. doi: 10.1037/a0029648. PMID: 22889336. IncludeDE_KQ2 Record ID 14654 [PMC free article: PMC3549033] [PubMed: 22889336] [CrossRef]

4.

Abikoff H, Hechtman L, Klein RG, et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):802–11. doi: 10.1097/01.chi.0000128791.10014.ac. PMID: 15213581. IncludeDE_KQ2 Record ID 14875 [PubMed: 15213581] [CrossRef]

5.

Abikoff H, Nissley-Tsiopinis J, Gallagher R, et al. Effects of MPH-OROS on the organizational, time management, and planning behaviors of children with ADHD. J Am Acad Child Adolesc Psychiatry. 2009 Feb;48(2):166–75. doi: 10.1097/CHI.0b013e3181930626. PMID: 19127171. IncludeDE_KQ2 Record ID 17420 [PubMed: 19127171] [CrossRef]

6.

Abikoff H, Vitiello B, Riddle M, et al. Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007;17(5):581–92. PMID: 17979579. IncludeDE_KQ2 Record ID 18292 [PubMed: 17979579]

7.

Abikoff HB, Thompson M, Laver-Bradbury C, et al. Parent training for preschool ADHD: a randomized controlled trial of specialized and generic programs. J Child Psychol Psychiatry. 2015 Jun;56(6):618–31. doi: 10.1111/jcpp.12346. PMID: 25318650. IncludeDE_KQ2 Record ID 15312 [PMC free article: PMC4400193] [PubMed: 25318650] [CrossRef]

8.

Abramov DM, Lazarev VV, Gomes SC, et al. Estimating biological accuracy of DSM for attention deficit/hyperactivity disorder based on multivariate analysis for small samples. PeerJ. 2019;2019(6). doi: 10.7717/peerj.7074. IncludeDE_KQ1 Record ID 6307 [CrossRef]

9.

Adams R, Finn P, Moes E, et al. Distractibility in Attention/Deficit/ Hyperactivity Disorder (ADHD): the virtual reality classroom. Child Neuropsychol. 2009 Mar;15(2):120–35. doi: 10.1080/09297040802169077. PMID: 18608217. IncludeDE_KQ1 Record ID 24382 [PubMed: 18608217] [CrossRef]

10.

Aevi Genomic Medicine L, a Cerecor company, Inc C. Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD. 2016. IncludeDE_KQ2 Record ID 13819

11.

Aevi Genomic Medicine L, a Cerecor company, Inc C. PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations. 2018. IncludeDE_KQ2 Record ID 13863

12.

Ahmadi A, Kashefi M, Shahrokhi H, et al. Computer aided diagnosis system using deep convolutional neural networks for ADHD subtypes. Biomedical Signal Processing and Control. 2021;63. doi: 10.1016/j.bspc.2020.102227. IncludeDE_KQ1 Record ID 6333 [CrossRef]

13.

Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry. 2004 Apr 8;4:9. doi: 10.1186/1471-244x-4-9. PMID: 15070418. IncludeDE_KQ2 Record ID 24386 [PMC free article: PMC400741] [PubMed: 15070418] [CrossRef]

14.

Algorta GP, Dodd AL, Stringaris A, et al. Diagnostic efficiency of the SDQ for parents to identify ADHD in the UK: a ROC analysis. Eur Child Adolesc Psychiatry. 2016 Sep;25(9):949–57. doi: 10.1007/s00787-015-0815-0. PMID: 26762184. IncludeDE_KQ1 Record ID 12707 [PMC free article: PMC4990620] [PubMed: 26762184] [CrossRef]

15.

Allen AJ, Kurlan RM, Gilbert DL, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology. 2005 Dec 27;65(12):1941–9. doi: 10.1212/01.wnl.0000188869.58300.a7. PMID: 16380617. IncludeDE_KQ2 Record ID 17787 [PubMed: 16380617] [CrossRef]

16.

Alloway TP, Gathercole SE, Holmes J, et al. The diagnostic utility of behavioral checklists in identifying children with ADHD and children with working memory deficits. Child Psychiatry Hum Dev. 2009 Sep;40(3):353–66. doi: 10.1007/s10578-009-0131-3. PMID: 19280339. IncludeDE_KQ1 Record ID 24671 [PubMed: 19280339] [CrossRef]

17.

Altınkaynak M, Dolu N, Güven A, et al. Diagnosis of Attention Deficit Hyperactivity Disorder with combined time and frequency features. Biocybernetics and Biomedical Engineering. 2020;40(3):927–37. doi: 10.1016/j.bbe.2020.04.006. IncludeDE_KQ1 Record ID 6402 [CrossRef]

18.

Amado-Caballero P, Casaseca-de-la-Higuera P, Alberola-Lopez S, et al. Objective ADHD Diagnosis Using Convolutional Neural Networks Over Daily-Life Activity Records. IEEE J Biomed Health Inform. 2020 Sep;24(9):2690–700. doi: 10.1109/jbhi.2020.2964072. PMID: 31905156. IncludeDE_KQ1 Record ID 3394 [PubMed: 31905156] [CrossRef]

19.

Amiri S, Mohammadi MR, Mohammadi M, et al. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):145–9. doi: 10.1016/j.pnpbp.2007.07.025. PMID: 17765380. IncludeDE_KQ2 Record ID 17500 [PubMed: 17765380] [CrossRef]

20.

Antshel KM, Remer R. Social skills training in children with attention deficit hyperactivity disorder: a randomized-controlled clinical trial. J Clin Child Adolesc Psychol. 2003 Mar;32(1):153–65. doi: 10.1207/S15374424JCCP3201_14. PMID: 12611031. IncludeDE_KQ2 Record ID 24627 [PubMed: 12611031] [CrossRef]

21.

Arjona A, Angulo-Ruiz BY, Rodríguez-Martínez EI, et al. Time-frequency neural dynamics of ADHD children and adolescents during a Working Memory task. Neurosci Lett. 2023 Feb 28;798:137100. doi: 10.1016/j.neulet.2023.137100. PMID: 36720344. IncludeDE_KQ1 Record ID 25630 [PubMed: 36720344] [CrossRef]

22.

Arnold LE, Amato A, Bozzolo H, et al. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol. 2007 Dec;17(6):791–802. doi: 10.1089/cap.2007.018. PMID: 18315451. IncludeDE_KQ2 Record ID 28665 [PubMed: 18315451] [CrossRef]

23.

Arnold LE, Arns M, Barterian JA, et al. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: 25-Month Follow-up of Double-Blind Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2022 Dec 8;62(4):435–46. doi: 10.1016/j.jaac.2022.07.862. PMID: 36521694. IncludeDE_KQ2 Record ID 23948 [PMC free article: PMC10065891] [PubMed: 36521694] [CrossRef]

24.

Ashkenasi A. Effect of transdermal methylphenidate wear times on sleep in children with attention deficit hyperactivity disorder. Pediatr Neurol. 2011 Dec;45(6):381–6. doi: 10.1016/j.pediatrneurol.2011.09.003. PMID: 22115000. IncludeDE_KQ2 Record ID 17185 [PubMed: 22115000] [CrossRef]

25.

Aviv TM, Katz YJ, Berant E. The Contribution of Therapeutic Horseback Riding to the Improvement of Executive Functions and Self-Esteem Among Children With ADHD. J Atten Disord. 2021 Oct;25(12):1743–53. doi: 10.1177/1087054720925898. PMID: 32508191. IncludeDE_KQ2 Record ID 27246 [PubMed: 32508191] [CrossRef]

26.

Azami S, Alimadadi Z, Ahmadi A, et al. The efficacy of cognitive-motor rehabilitation on cognitive functions and behavioral symptoms of attention deficit/hyperactivity disorder (ADHD) children: Specification of near-transfer and far-transfer effects in comparison to medication. J Educ Health Promot. 2023;12:64. doi: 10.4103/jehp.jehp_189_22. PMID: 37113411. IncludeDE_KQ2 Record ID 28210 [PMC free article: PMC10127477] [PubMed: 37113411] [CrossRef]

27.

Bakhshayesh AR, Hänsch S, Wyschkon A, et al. Neurofeedback in ADHD: a single-blind randomized controlled trial. Eur Child Adolesc Psychiatry. 2011 Sep;20(9):481–91. doi: 10.1007/s00787-011-0208-y. PMID: 21842168. IncludeDE_KQ2 Record ID 17184 [PubMed: 21842168] [CrossRef]

28.

Banaschewski T, Soutullo C, Lecendreux M, et al. Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder. CNS Drugs. 2013 Oct;27(10):829–40. doi: 10.1007/s40263-013-0095-5. PMID: 23893527. IncludeDE_KQ2 Record ID 14417 [PMC free article: PMC3784063] [PubMed: 23893527] [CrossRef]

29.

Bangs ME, Emslie GJ, Spencer TJ, et al. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. J Child Adolesc Psychopharmacol. 2007 Aug;17(4):407–20. doi: 10.1089/cap.2007.0066. PMID: 17822337. IncludeDE_KQ2 Record ID 17598 [PubMed: 17822337] [CrossRef]

30.

Bangs ME, Hazell P, Danckaerts M, et al. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics. 2008 Feb;121(2):e314–20. doi: 10.1542/peds.2006-1880. PMID: 18245404. IncludeDE_KQ2 Record ID 24404 [PubMed: 18245404] [CrossRef]

31.

Bansal R, Staib LH, Laine AF, et al. Anatomical brain images alone can accurately diagnose chronic neuropsychiatric illnesses. PLoS One. 2012;7(12):e50698. doi: 10.1371/journal.pone.0050698. PMID: 23236384. IncludeDE_KQ1 Record ID 18 [PMC free article: PMC3517530] [PubMed: 23236384] [CrossRef]

32.

Bard DE, Wolraich ML, Neas B, et al. The psychometric properties of the Vanderbilt attention-deficit hyperactivity disorder diagnostic parent rating scale in a community population. J Dev Behav Pediatr. 2013 Feb;34(2):72–82. doi: 10.1097/DBP.0b013e31827a3a22. PMID: 23363972. IncludeDE_KQ1 Record ID 27337 [PubMed: 23363972] [CrossRef]

33.

Barkley RA, Grodzinsky GM. Are tests of frontal lobe functions useful in the diagnosis of attention deficit disorders? Clinical Neuropsychologist. 1994;8(2):121–39. doi: 10.1080/13854049408401552. IncludeDE_KQ1 Record ID 27282 [CrossRef]

34.

Baziar S, Aqamolaei A, Khadem E, et al. Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study. J Child Adolesc Psychopharmacol. 2019 Apr;29(3):205–12. doi: 10.1089/cap.2018.0146. PMID: 30741567. IncludeDE_KQ2 Record ID 287 [PubMed: 30741567] [CrossRef]

35.

Bédard AC SM, Halperin JM, Krone B, Rajwan E, Newcorn JH. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder. J Child Psychol Psychiatry. 2015 Jan;56(1):40–8. doi: 10.1111/jcpp.12272. PMID: 24942409. IncludeDE_KQ2 Record ID 19249 [PMC free article: PMC4272337] [PubMed: 24942409] [CrossRef]

36.

Behdani F, Hebrani P, Naseraee A, et al. Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients? J Res Med Sci. 2013 Aug;18(8):653–8. PMID: 24379840. IncludeDE_KQ2 Record ID 27189 [PMC free article: PMC3872603] [PubMed: 24379840]

37.

Benzing V, Schmidt M. The effect of exergaming on executive functions in children with ADHD: A randomized clinical trial. Scand J Med Sci Sports. 2019 Aug;29(8):1243–53. doi: 10.1111/sms.13446. PMID: 31050851. IncludeDE_KQ2 Record ID 258 [PubMed: 31050851] [CrossRef]

38.

Berger I, Slobodin O, Cassuto H. Usefulness and Validity of Continuous Performance Tests in the Diagnosis of Attention-Deficit Hyperactivity Disorder Children. Arch Clin Neuropsychol. 2017 Feb;32(1):81–93. doi: 10.1093/arclin/acw101. PMID: 28122767. IncludeDE_KQ1 Record ID 859 [PubMed: 28122767] [CrossRef]

39.

Berger I GG. Objective measures of attention-deficit/hyperactivity disorder: a pilot study. Isr Med Assoc J. 2010 Sep;12(9):531–5. PMID: 21287795. IncludeDE_KQ1 Record ID 17002 [PubMed: 21287795]

40.

Bergeron L, Smolla N, Berthiaume C, et al. Reliability, Validity, and Clinical Utility of the Dominic Interactive for Adolescents-Revised(A DSM-5-Based Self-Report Screen for Mental Disorders, Borderline Personality Traits, and Suicidality). Can J Psychiatry. 2017 Mar;62(3):211–22. doi: 10.1177/0706743716670129. PMID: 27638424. IncludeDE_KQ1 Record ID 27340 [PMC free article: PMC5317018] [PubMed: 27638424] [CrossRef]

41.

Beriha SS. Computer aided diagnosis system to distinguish adhd from similar behavioral disorders. Biomedical and Pharmacology Journal. 2018;11(2):1135–41. doi: 10.13005/bpj/1474. IncludeDE_KQ1 Record ID 6627 [CrossRef]

42.

Biederman J, Krishnan S, Zhang Y, et al. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007 Mar;29(3):450–63. doi: 10.1016/s0149-2918(07)80083-x. PMID: 17577466. IncludeDE_KQ2 Record ID 24396 [PubMed: 17577466] [CrossRef]

43.

Biederman J, Melmed RD, Patel A, et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008 Jan;121(1):e73–84. doi: 10.1542/peds.2006-3695. PMID: 18166547. IncludeDE_KQ2 Record ID 17495 [PubMed: 18166547] [CrossRef]

44.

Biederman J, Swanson JM, Wigal SB, et al. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Clin Psychiatry. 2006 May;67(5):727–35. doi: 10.4088/jcp.v67n0506. PMID: 16841622. IncludeDE_KQ2 Record ID 17689 [PubMed: 16841622] [CrossRef]

45.

Biederman J, Swanson JM, Wigal SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics. 2005 Dec;116(6):e777–84. doi: 10.1542/peds.2005-0617. PMID: 16322134. IncludeDE_KQ2 Record ID 17782 [PubMed: 16322134] [CrossRef]

46.

Bigorra A, Garolera M, Guijarro S, et al. Long-term far-transfer effects of working memory training in children with ADHD: a randomized controlled trial. Eur Child Adolesc Psychiatry. 2016 Aug;25(8):853–67. doi: 10.1007/s00787-015-0804-3. PMID: 26669692. IncludeDE_KQ2 Record ID 12758 [PubMed: 26669692] [CrossRef]

47.

Bikic A, Leckman JF, Christensen TØ, et al. Attention and executive functions computer training for attention-deficit/hyperactivity disorder (ADHD): results from a randomized, controlled trial. European Child & Adolescent Psychiatry. 2018 2018/12/01;27(12):1563–74. doi: 10.1007/s00787-018-1151-y. PMID: 29644473. IncludeDE_KQ2 Record ID 40 [PubMed: 29644473] [CrossRef]

48.

Bilici M, Yildirim F, Kandil S, et al. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):181–90. doi: 10.1016/j.pnpbp.2003.09.034. PMID: 14687872. IncludeDE_KQ2 Record ID 15098 [PubMed: 14687872] [CrossRef]

49.

Binesh M, Daghighi MR, Shirazi E, et al. Comparison of Auricular Therapy with Sham in Children with Attention Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. J Altern Complement Med. 2020 Jun;26(6):515–20. doi: 10.1089/acm.2019.0477. PMID: 32434376. IncludeDE_KQ2 Record ID 311 [PubMed: 32434376] [CrossRef]

50.

Blader JC, Pliszka SR, Kafantaris V, et al. Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization. J Am Acad Child Adolesc Psychiatry. 2021 Feb;60(2):236–51. doi: 10.1016/j.jaac.2019.12.009. PMID: 32007604. IncludeDE_KQ2 Record ID 356 [PMC free article: PMC7390668] [PubMed: 32007604] [CrossRef]

51.

Bledsoe JC, Xiao C, Chaovalitwongse A, et al. Diagnostic Classification of ADHD Versus Control: Support Vector Machine Classification Using Brief Neuropsychological Assessment. J Atten Disord. 2020 Sep;24(11):1547–56. doi: 10.1177/1087054716649666. PMID: 27231214. IncludeDE_KQ1 Record ID 723 [PubMed: 27231214] [CrossRef]

52.

Bloch Y FM, Maoz H, et al. Can computerized cognitive tests assist in the clinical diagnosis of attention-deficit hyperactivity disorder? J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):111–4. doi: 10.1176/appi.neuropsych.11010014. PMID: 22450621. IncludeDE_KQ1 Record ID 17003 [PubMed: 22450621] [CrossRef]

53.

Block SL, Kelsey D, Coury D, et al. Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing. Clin Pediatr (Phila). 2009 Sep;48(7):723–33. doi: 10.1177/0009922809335321. PMID: 19420182. IncludeDE_KQ2 Record ID 19273 [PubMed: 19420182] [CrossRef]

54.

Blumer JL, Findling RL, Shih WJ, et al. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/hyperactivity disorder in children 6 to 17 years of age. Pediatrics. 2009 May;123(5):e770–6. doi: 10.1542/peds.2008-2945. PMID: 19403468. IncludeDE_KQ2 Record ID 14969 [PubMed: 19403468] [CrossRef]

55.

Bluschke A, Eggert E, Friedrich J, et al. The Effects of Different Theta and Beta Neurofeedback Training Protocols on Cognitive Control in ADHD. J Cogn Enhanc. 2022;6(4):463–77. doi: 10.1007/s41465-022-00255-6. PMID: 36373033. IncludeDE_KQ2 Record ID 24216 [PMC free article: PMC9638270] [PubMed: 36373033] [CrossRef]

56.

Boroujeni YK, Rastegari AA, Khodadadi H. Diagnosis of attention deficit hyperactivity disorder using non-linear analysis of the EEG signal. IET Syst Biol. 2019 Oct;13(5):260–6. doi: 10.1049/iet-syb.2018.5130. PMID: 31538960. IncludeDE_KQ1 Record ID 1013 [PMC free article: PMC8687398] [PubMed: 31538960] [CrossRef]

57.

Bostic JQ, Biederman J, Spencer TJ, et al. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. J Child Adolesc Psychopharmacol. 2000 Fall;10(3):205–16. doi: 10.1089/10445460050167313. PMID: 11052410. IncludeDE_KQ2 Record ID 18016 [PubMed: 11052410] [CrossRef]

58.

Boucugnani LL, Jones RW. Behaviors analogous to frontal lobe dysfunction in children with attention deficit hyperactivity disorder. Archives of Clinical Neuropsychology. 1989 1989/01/01/;4(2):161–73. doi: 10.1016/0887-6177(89)90154-6. IncludeDE_KQ1 Record ID 24524 [CrossRef]

59.

Boyer BE, Geurts HM, Prins PJ, et al. One-year follow-up of two novel CBTs for adolescents with ADHD. Eur Child Adolesc Psychiatry. 2016 Mar;25(3):333–7. doi: 10.1007/s00787-015-0776-3. PMID: 26433369. IncludeDE_KQ2 Record ID 13667 [PubMed: 26433369] [CrossRef]

60.

Brams M, Childress AC, Greenbaum M, et al. SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study. J Child Adolesc Psychopharmacol. 2018 Feb;28(1):19–28. doi: 10.1089/cap.2017.0053. PMID: 28816509. IncludeDE_KQ2 Record ID 514 [PMC free article: PMC5771539] [PubMed: 28816509] [CrossRef]

61.

Breaux RP, Griffith SF, Harvey EA. Preschool Neuropsychological Measures as Predictors of Later Attention Deficit Hyperactivity Disorder. J Abnorm Child Psychol. 2016 Nov;44(8):1455–71. doi: 10.1007/s10802-016-0140-1. PMID: 26936037. IncludeDE_KQ1 Record ID 1140 [PMC free article: PMC5010792] [PubMed: 26936037] [CrossRef]

62.

Breaux RP, Langberg JM, McLeod BD, et al. The importance of therapeutic processes in school-based psychosocial treatment of homework problems in adolescents with ADHD. J Consult Clin Psychol. 2018 May;86(5):427–38. doi: 10.1037/ccp0000300. PMID: 29683700. IncludeDE_KQ2 Record ID 1969 [PubMed: 29683700] [CrossRef]

63.

Buitelaar JK, Michelson D, Danckaerts M, et al. A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year. Biol Psychiatry. 2007 Mar 1;61(5):694–9. doi: 10.1016/j.biopsych.2006.03.066. PMID: 16893523. IncludeDE_KQ2 Record ID 17592 [PubMed: 16893523] [CrossRef]

64.

Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, et al. Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects. J Child Psychol Psychiatry. 1996 Jul;37(5):587–95. doi: 10.1111/j.1469-7610.1996.tb01445.x. PMID: 8807439. IncludeDE_KQ2 Record ID 18103 [PubMed: 8807439] [CrossRef]

65.

Bul KC, Kato PM, Van der Oord S, et al. Behavioral Outcome Effects of Serious Gaming as an Adjunct to Treatment for Children With Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. J Med Internet Res. 2016 Feb 16;18(2):e26. doi: 10.2196/jmir.5173. PMID: 26883052. IncludeDE_KQ2 Record ID 12787 [PMC free article: PMC4773597] [PubMed: 26883052] [CrossRef]

66.

Bunte TL LS, Schoemaker K, et al. Clinical usefulness of observational assessment in the diagnosis of DBD and ADHD in preschoolers. J Clin Child Adolesc Psychol. 2013;42(6):749–61. doi: 10.1080/15374416.2013.773516. IncludeDE_KQ1 Record ID 17016 [PubMed: 23477379] [CrossRef]

67.

Burton CL, Wright L, Shan J, et al. SWAN scale for ADHD trait-based genetic research: a validity and polygenic risk study. J Child Psychol Psychiatry. 2019 Sep;60(9):988–97. doi: 10.1111/jcpp.13032. PMID: 30908652. IncludeDE_KQ1 Record ID 615 [PubMed: 30908652] [CrossRef]

68.

Bussing R, Schuhmann E, Belin TR, et al. Diagnostic utility of two commonly used ADHD screening measures among special education students. J Am Acad Child Adolesc Psychiatry. 1998 Jan;37(1):74–82. doi: 10.1097/00004583-199801000-00020. PMID: 9444903. IncludeDE_KQ1 Record ID 24672 [PubMed: 9444903] [CrossRef]

69.

Canivez GL, Gaboury AR. Construct Validity and Diagnostic Utility of the Cognitive Assessment System for ADHD. J Atten Disord. 2016 Jun;20(6):519–29. doi: 10.1177/1087054713489021. PMID: 23757332. IncludeDE_KQ1 Record ID 12798 [PubMed: 23757332] [CrossRef]

70.

Carucci S, Romaniello R, Demuru G, et al. Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children. Eur Arch Psychiatry Clin Neurosci. 2022 Dec;272(8):1453–67. doi: 10.1007/s00406-022-01428-2. PMID: 35672606. IncludeDE_KQ2 Record ID 25728 [PubMed: 35672606] [CrossRef]

71.

Catherine Joy R, Thomas George S, Albert Rajan A, et al. Detection of ADHD From EEG Signals Using Different Entropy Measures and ANN. Clin EEG Neurosci. 2021 Aug 23:15500594211036788. doi: 10.1177/15500594211036788. PMID: 34424101. IncludeDE_KQ1 Record ID 3522 [PubMed: 34424101] [CrossRef]

72.

Cedergren K, Ostlund S, Asberg Johnels J, et al. Monitoring medication response in ADHD: what can continuous performance tests tell us? Eur Arch Psychiatry Clin Neurosci. 2022 Mar;272(2):291–9. doi: 10.1007/s00406-021-01319-y. PMID: 34420075. IncludeDE_KQ3 Record ID 19201 [PMC free article: PMC8866368] [PubMed: 34420075] [CrossRef]

73.

Ceresoli-Borroni G, Nasser A, Adewole T, et al. A Double-Blind, Randomized Study of Extended-Release Molindone for Impulsive Aggression in ADHD. J Atten Disord. 2021 Sep;25(11):1564–77. doi: 10.1177/1087054720909084. PMID: 32338106. IncludeDE_KQ2 Record ID 3470 [PubMed: 32338106] [CrossRef]

74.

Çetin FH, Taş Torun Y, Işik Taner Y. Atomoxetine versus OROS methylphenidate in attention deficit hyperactivity disorder: A six-month follow up study for efficacy and adverse effects. Dikkat eksikliği hiperaktivite bozukluğu tedavisinde atomoksetin ve osmotik salınımlı metilfenidat: Etkinlik ve yan etki profilinin değerlendirildiği Altı Aylık İzlem Çalışması. 2015;35(2):88–96. doi: 10.5336/medsci.2015-43336. IncludeDE_KQ2 Record ID 15933 [CrossRef]

75.

Chacko A WB, Wymbs FA, et al. . Enhancing traditional behavioral parent training for single mothers of children with ADHD. J Clin Child Adolesc Psychol. 2009 Mar;38(2):206–18. doi: 10.1080/15374410802698388. IncludeDE_KQ2 Record ID 17047 [PubMed: 19283599] [CrossRef]

76.

Chan AS, Ding Z, Lee TL, et al. Temporal processing deficit in children with attention-deficit/hyperactivity disorder: An online assessment. Digit Health. 2022 Jan–Dec;8:20552076221120325. doi: 10.1177/20552076221120325. PMID: 36060612. IncludeDE_KQ1 Record ID 23905 [PMC free article: PMC9434659] [PubMed: 36060612] [CrossRef]

77.

Chang JP, Su KP, Mondelli V, et al. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels. Transl Psychiatry. 2019 Nov 20;9(1):303. doi: 10.1038/s41398-019-0633-0. PMID: 31745072. IncludeDE_KQ2 Record ID 4092 [PMC free article: PMC6864068] [PubMed: 31745072] [CrossRef]

78.

Chang MY, Ouyang CS, Chiang CT, et al. A New Method of Diagnosing Attention-Deficit Hyperactivity Disorder in Male Patients by Quantitative EEG Analysis. Clin EEG Neurosci. 2019 Sep;50(5):339–47. doi: 10.1177/1550059419859164. PMID: 31321994. IncludeDE_KQ1 Record ID 1507 [PubMed: 31321994] [CrossRef]

79.

Chang SH, Shie JJ, Yu NY. Enhancing Executive Functions and Handwriting with a Concentrative Coordination Exercise in Children with ADHD: A Randomized Clinical Trial. Percept Mot Skills. 2022 Aug;129(4):1014–35. doi: 10.1177/00315125221098324. PMID: 35507726. IncludeDE_KQ2 Record ID 25744 [PubMed: 35507726] [CrossRef]

80.

Chang TM, Wu RC, Yang RC, et al. Objective diagnosis of ADHD through movement analysis by using a smart chair with piezoelectric material. Pediatr Neonatol. 2023 Jan;64(1):46–52. doi: 10.1016/j.pedneo.2022.06.007. PMID: 36089537. IncludeDE_KQ1 Record ID 25745 [PubMed: 36089537] [CrossRef]

81.

Chang Y, Stevenson C, Chen IC, et al. Neurological state changes indicative of ADHD in children learned via EEG-based LSTM networks. J Neural Eng. 2022 Feb 10;19(1). doi: 10.1088/1741-2552/ac4f07. PMID: 35081524. IncludeDE_KQ1 Record ID 25746 [PubMed: 35081524] [CrossRef]

82.

Charach A, Chen S, Hogg-Johnson S, et al. Using the Conners’ Teacher Rating Scale-Revised in school children referred for assessment. Can J Psychiatry. 2009 Apr;54(4):232–41. doi: 10.1177/070674370905400404. PMID: 19321029. IncludeDE_KQ1 Record ID 27341 [PubMed: 19321029] [CrossRef]

83.

Chelune GJ, Ferguson W, Koon R, et al. Frontal lobe disinhibition in attention deficit disorder. Child Psychiatry Hum Dev. 1986 Summer;16(4):221–34. doi: 10.1007/BF00706479. PMID: 3743175. IncludeDE_KQ1 Record ID 24535 [PubMed: 3743175] [CrossRef]

84.

Chen C, Li Z, Liu X, et al. Cognitive Control Deficits in Children With Subthreshold Attention-Deficit/Hyperactivity Disorder. Front Hum Neurosci. 2022;16:835544. doi: 10.3389/fnhum.2022.835544. PMID: 35360286. IncludeDE_KQ1 Record ID 23896 [PMC free article: PMC8963720] [PubMed: 35360286] [CrossRef]

85.

Chen CC, Wu EHK, Chen YQ, et al. Neuronal Correlates of Task Irrelevant Distractions Enhance the Detection of Attention Deficit/Hyperactivity Disorder. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 2023;31:1302–10. doi: 10.1109/TNSRE.2023.3241649. IncludeDE_KQ1 Record ID 25751 [CrossRef]

86.

Chen H, Chen W, Song Y, et al. EEG characteristics of children with attention-deficit/hyperactivity disorder. Neuroscience. 2019 May 15;406:444–56. doi: 10.1016/j.neuroscience.2019.03.048. PMID: 30926547. IncludeDE_KQ1 Record ID 2190 [PubMed: 30926547] [CrossRef]

87.

Chen H, Song Y, Li X. A deep learning framework for identifying children with ADHD using an EEG-based brain network. Neurocomputing. 2019;356:83–96. doi: 10.1016/j.neucom.2019.04.058. IncludeDE_KQ1 Record ID 6911 [CrossRef]

88.

Chen IC, Lee PW, Wang LJ, et al. Incremental Validity of Multi-Method and Multi-Informant Evaluations in the Clinical Diagnosis of Preschool ADHD. J Atten Disord. 2021 Dec 23:10870547211045739. doi: 10.1177/10870547211045739. PMID: 34949123. IncludeDE_KQ1 Record ID 18885 [PubMed: 34949123] [CrossRef]

89.

Chen WJ, Faraone SV, Biederman J, et al. Diagnostic accuracy of the Child Behavior Checklist scales for attention-deficit hyperactivity disorder: a receiver-operating characteristic analysis. J Consult Clin Psychol. 1994 Oct;62(5):1017–25. doi: 10.1037/0022-006x.62.5.1017. PMID: 7806710. IncludeDE_KQ1 Record ID 22629 [PubMed: 7806710] [CrossRef]

90.

Chen Y, Tang Y, Wang C, et al. ADHD classification by dual subspace learning using resting-state functional connectivity. Artif Intell Med. 2020 Mar;103:101786. doi: 10.1016/j.artmed.2019.101786. PMID: 32143793. IncludeDE_KQ1 Record ID 1474 [PubMed: 32143793] [CrossRef]

91.

Chiarenza GA, Villa S, Galan L, et al. Junior temperament character inventory together with quantitative EEG discriminate children with attention deficit hyperactivity disorder combined subtype from children with attention deficit hyperactivity disorder combined subtype plus oppositional defiant disorder. Int J Psychophysiol. 2018 Aug;130:9–20. doi: 10.1016/j.ijpsycho.2018.05.007. PMID: 29787785. IncludeDE_KQ1 Record ID 1621 [PubMed: 29787785] [CrossRef]

92.

Children’s Hospital Medical Center CSCsH. The Effects of ADHD Medication (TEAM) Study. 2015. IncludeDE_KQ2 Record ID 27077

93.

Childress AC, Lloyd E, Jacobsen L, et al. Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2022 May 13. doi: 10.1016/j.jaac.2022.03.034. PMID: 35577034. IncludeDE_KQ2 Record ID 19351 [PubMed: 35577034] [CrossRef]

94.

Childress AC, Spencer T, Lopez F, et al. Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Aug;19(4):351–61. doi: 10.1089/cap.2009.0007. PMID: 19702487. IncludeDE_KQ2 Record ID 27156 [PubMed: 19702487] [CrossRef]

95.

Cho S, Lee SI, Yoo H, et al. A randomized, open-label assessment of response to various doses of atomoxetine in Korean pediatric outpatients with attention-deficit/hyperactivity disorder. Psychiatry Investigation. 2011;8(2):141–8. doi: 10.4306/pi.2011.8.2.141. IncludeDE_KQ2 Record ID 18443 [PMC free article: PMC3149109] [PubMed: 21852991] [CrossRef]

96.

Chow JC, Ouyang CS, Chiang CT, et al. Novel method using Hjorth mobility analysis for diagnosing attention-deficit hyperactivity disorder in girls. Brain Dev. 2019 Apr;41(4):334–40. doi: 10.1016/j.braindev.2018.11.006. PMID: 30473392. IncludeDE_KQ1 Record ID 1000 [PubMed: 30473392] [CrossRef]

97.

Chu KC, Huang YS, Tseng CF, et al. Reliability and validity of DS-ADHD: A decision support system on attention deficit hyperactivity disorders. Comput Methods Programs Biomed. 2017 Mar;140:241–8. doi: 10.1016/j.cmpb.2016.12.003. PMID: 28254080. IncludeDE_KQ1 Record ID 783 [PubMed: 28254080] [CrossRef]

98.

Chu L, Zhu P, Ma C, et al. Effects of Combing Group Executive Functioning and Online Parent Training on School-Aged Children With ADHD: A Randomized Controlled Trial. Front Pediatr. 2021;9:813305. doi: 10.3389/fped.2021.813305. PMID: 35223713. IncludeDE_KQ2 Record ID 18891 [PMC free article: PMC8874140] [PubMed: 35223713] [CrossRef]

99.

Churchill SS, Leo MC, Brennan EM, et al. Longitudinal Impact of a Randomized Clinical Trial to Improve Family Function, Reduce Maternal Stress and Improve Child Outcomes in Families of Children with ADHD. Matern Child Health J. 2018 Aug;22(8):1172–82. doi: 10.1007/s10995-018-2502-5. PMID: 29476416. IncludeDE_KQ2 Record ID 1761 [PubMed: 29476416] [CrossRef]

100.

Coelho LF, Barbosa DLF, Rizzutti S, et al. Group cognitive behavioral therapy for children and adolescents with ADHD. Psicol Reflex Crit. 2017 May 16;30(1):11. doi: 10.1186/s41155-017-0063-y. PMID: 32026094. IncludeDE_KQ2 Record ID 4145 [PMC free article: PMC6967068] [PubMed: 32026094] [CrossRef]

101.

Coghill DR, Banaschewski T, Lecendreux M, et al. Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design. J Am Acad Child Adolesc Psychiatry. 2014 Jun;53(6):647–57.e1. doi: 10.1016/j.jaac.2014.01.017. PMID: 24839883. IncludeDE_KQ2 Record ID 14575 [PubMed: 24839883] [CrossRef]

102.

Cohen ML, Kelly PC, Atkinson AW. Parent, teacher, child. A trilateral approach to attention deficit disorder. Am J Dis Child. 1989 Oct;143(10):1229–33. PMID: 2801667. IncludeDE_KQ3 Record ID 15286 [PubMed: 2801667]

103.

Coles EK, Pelham WE, Fabiano GA, et al. Randomized Trial of First-Line Behavioral Intervention to Reduce Need for Medication in Children with ADHD. J Clin Child Adolesc Psychol. 2020 Sep–Oct;49(5):673–87. doi: 10.1080/15374416.2019.1630835. PMID: 31411903. IncludeDE_KQ2 Record ID 4155 [PMC free article: PMC7018583] [PubMed: 31411903] [CrossRef]

104.

Concordia Pharmaceuticals Inc. B. Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder. 2011. IncludeDE_KQ2 Record ID 13782

105.

Conners CK, Casat CD, Gualtieri CT, et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1314–21. doi: 10.1097/00004583-199610000-00018. PMID: 8885585. IncludeDE_KQ2 Record ID 24393 [PubMed: 8885585] [CrossRef]

106.

Connor DF FR, Kollins SH, Sallee F, López FA, Lyne A, Tremblay G. Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. CNS Drugs. 2010 Sep;24(9):755–68. doi: 10.2165/11537790-000000000-00000. PMID: 20806988. IncludeDE_KQ2 Record ID 19254 [PubMed: 20806988] [CrossRef]

107.

Corkum P, Elik N, Blotnicky-Gallant PAC, et al. Web-Based Intervention for Teachers of Elementary Students With ADHD: Randomized Controlled Trial. J Atten Disord. 2019 Feb;23(3):257–69. doi: 10.1177/1087054715603198. PMID: 26362259. IncludeDE_KQ2 Record ID 377 [PubMed: 26362259] [CrossRef]

108.

Cornu C, Mercier C, Ginhoux T, et al. A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms. Eur Child Adolesc Psychiatry. 2018 Mar;27(3):377–84. doi: 10.1007/s00787-017-1058-z. PMID: 28993963. IncludeDE_KQ2 Record ID 283 [PubMed: 28993963] [CrossRef]

109.

Cree RA, Bitsko RH, Danielson ML, et al. Surveillance of ADHD Among Children in the United States: Validity and Reliability of Parent Report of Provider Diagnosis. J Atten Disord. 2023 Jan;27(2):111–23. doi: 10.1177/10870547221131979. PMID: 36326292. IncludeDE_KQ1 Record ID 25814 [PMC free article: PMC9843610] [PubMed: 36326292] [CrossRef]

110.

Crippa A, Salvatore C, Molteni E, et al. The Utility of a Computerized Algorithm Based on a Multi-Domain Profile of Measures for the Diagnosis of Attention Deficit/Hyperactivity Disorder. Front Psychiatry. 2017;8:189. doi: 10.3389/fpsyt.2017.00189. PMID: 29042856. IncludeDE_KQ1 Record ID 3324 [PMC free article: PMC5632354] [PubMed: 29042856] [CrossRef]

111.

Crippa A, Tesei A, Sangiorgio F, et al. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial. Eur Child Adolesc Psychiatry. 2019 Apr;28(4):571–83. doi: 10.1007/s00787-018-1223-z. PMID: 30246216. IncludeDE_KQ2 Record ID 455 [PubMed: 30246216] [CrossRef]

112.

Culbertson WC, Zillmer EA. The Tower of LondonDX: A Standardized Approach to Assessing Executive Functioning in Children. Archives of Clinical Neuropsychology. 1998 1998/04/01/;13(3):285–301. doi: 10.1016/S0887-6177(97)00033-4. IncludeDE_KQ1 Record ID 24538 [PubMed: 14590643] [CrossRef]

113.

Das W, Khanna S. A Robust Machine Learning Based Framework for the Automated Detection of ADHD Using Pupillometric Biomarkers and Time Series Analysis. Sci Rep. 2021 Aug 12;11(1):16370. doi: 10.1038/s41598-021-95673-5. PMID: 34385511. IncludeDE_KQ1 Record ID 12865 [PMC free article: PMC8361128] [PubMed: 34385511] [CrossRef]

114.

Dashbozorgi Z, Ghaffari A, Karamali Esmaili S, et al. Effect of Neurofeedback Training on Aggression and Impulsivity in Children With Attention-Deficit/Hyperactivity Disorder: A Double-Blinded Randomized Controlled Trial. Basic Clin Neurosci. 2021 Sep–Oct;12(5):693–702. doi: 10.32598/bcn.2021.2363.1. PMID: 35173923. IncludeDE_KQ2 Record ID 18905 [PMC free article: PMC8818111] [PubMed: 35173923] [CrossRef]

115.

David D, Dobrean A, Păsărelu CR, et al. Psychotherapy, Atomoxetine or Both? Preliminary Evidence from a Comparative Study of Three Types of Treatment for Attention-Deficit/Hyperactivity Disorder in Children. Cognitive Therapy and Research. 2021;45(1):149–65. doi: 10.1007/s10608-020-10157-6. IncludeDE_KQ2 Record ID 7107 [CrossRef]

116.

Daviss WB, Patel NC, Robb AS, et al. Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):189–98. doi: 10.1097/chi.0b013e31815d9ae4. PMID: 18182964. IncludeDE_KQ2 Record ID 15335 [PubMed: 18182964] [CrossRef]

117.

Deb S, Dhaliwal AJ, Roy M. The usefulness of Conners’ Rating Scales-Revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence. J Intellect Disabil Res. 2008 Nov;52(11):950–65. doi: 10.1111/j.1365-2788.2007.01035.x. PMID: 18179511. IncludeDE_KQ1 Record ID 22703 [PubMed: 18179511] [CrossRef]

118.

Dehbozorghi S, Bagheri S, Moradi K, et al. Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial. Psychiatry and Clinical Neurosciences. 2019 Nov 2019;73(11):690–6. IncludeDE_KQ2 Record ID 11268 [PubMed: 31294924]

119.

Dell’Agnello G, Maschietto D, Bravaccio C, et al. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study. Eur Neuropsychopharmacol. 2009 Nov;19(11):822–34. doi: 10.1016/j.euroneuro.2009.07.008. PMID: 19716683. IncludeDE_KQ2 Record ID 17394 [PubMed: 19716683] [CrossRef]

120.

Denton CA, Tamm L, Schatschneider C, et al. The Effects of ADHD Treatment and Reading Intervention on the Fluency and Comprehension of Children with ADHD and Word Reading Difficulties: A Randomized Clinical Trial. Sci Stud Read. 2020;24(1):72–89. doi: 10.1080/10888438.2019.1640704. PMID: 32982141. IncludeDE_KQ2 Record ID 4205 [PMC free article: PMC7518569] [PubMed: 32982141] [CrossRef]

121.

Dentz A, Guay MC, Gauthier B, et al. Is the Cogmed program effective for youths with attention deficit/hyperactivity disorder under pharmacological treatment? Applied Cognitive Psychology. 2020;34(3):577–89. doi: 10.1002/acp.3631. IncludeDE_KQ2 Record ID 7159 [CrossRef]

122.

Deserno MK, Bathelt J, Groenman AP, et al. Probing the overarching continuum theory: data-driven phenotypic clustering of children with ASD or ADHD. Eur Child Adolesc Psychiatry. 2022 Jun 10. doi: 10.1007/s00787-022-01986-9. PMID: 35687205. IncludeDE_KQ1 Record ID 24006 [PMC free article: PMC10533623] [PubMed: 35687205] [CrossRef]

123.

Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1999 Apr;38(4):402–9. doi: 10.1097/00004583-199904000-00012. PMID: 10199111. IncludeDE_KQ2 Record ID 24378 [PubMed: 10199111] [CrossRef]

124.

Dittmann RW, Cardo E, Nagy P, et al. Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study. CNS Drugs. 2013 Dec;27(12):1081–92. doi: 10.1007/s40263-013-0104-8. PMID: 23959815. IncludeDE_KQ2 Record ID 14787 [PMC free article: PMC3835923] [PubMed: 23959815] [CrossRef]

125.

Dittmann RW, Schacht A, Helsberg K, et al. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany. J Child Adolesc Psychopharmacol. 2011 Apr;21(2):97–110. doi: 10.1089/cap.2009.0111. PMID: 21488751. IncludeDE_KQ2 Record ID 17163 [PubMed: 21488751] [CrossRef]

126.

Dong Y, Chow BW, Mo J, et al. Dialogic reading with attention-deficit-hyperactivity disorder (ADHD) kindergarteners: Does reading with parents or siblings enhance their language development? Dev Psychol. 2022 Oct 6;59(5):862–73. doi: 10.1037/dev0001466. PMID: 36201815. IncludeDE_KQ2 Record ID 24178 [PubMed: 36201815] [CrossRef]

127.

Dose C, Hautmann C, Buerger M, et al. Telephone-assisted self-help for parents of children with attention-deficit/hyperactivity disorder who have residual functional impairment despite methylphenidate treatment: a randomized controlled trial. J Child Psychol Psychiatry. 2017 Jun;58(6):682–90. doi: 10.1111/jcpp.12661. PMID: 27878809. IncludeDE_KQ2 Record ID 4219 [PubMed: 27878809] [CrossRef]

128.

Dovis S, Van der Oord S, Wiers RW, et al. Improving executive functioning in children with ADHD: training multiple executive functions within the context of a computer game. a randomized double-blind placebo controlled trial. PLoS One. 2015;10(4):e0121651. doi: 10.1371/journal.pone.0121651. PMID: 25844638. IncludeDE_KQ2 Record ID 14688 [PMC free article: PMC4386826] [PubMed: 25844638] [CrossRef]

129.

Doyle A, Ostrander R, Skare S, et al. Convergent and criterion-related validity of the Behavior Assessment System for Children-Parent Rating Scale. J Clin Child Psychol. 1997 Sep;26(3):276–84. doi: 10.1207/s15374424jccp2603_6. PMID: 9292385. IncludeDE_KQ1 Record ID 27342 [PubMed: 9292385] [CrossRef]

130.

Doyle R, Mick E, Biederman J. Convergence between the Achenbach youth self-report and structured diagnostic interview diagnoses in ADHD and non-ADHD youth. J Nerv Ment Dis. 2007 Apr;195(4):350–2. doi: 10.1097/01.nmd.0000253732.79172.43. PMID: 17435486. IncludeDE_KQ1 Record ID 22725 [PubMed: 17435486] [CrossRef]

131.

Dreakhshanpour PF, Deylamsalehi A, Moghaddas SSJ, et al. EFFICACY OF ARIPIPRAZOLE AND RISPERIDONE IN TREATMENT OF CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: A DOUBLE-BLIND CLINICAL TRIAL STUDY. Bulletin of Pharmaceutical Sciences. Assiut. 2022;45(1):281–8. doi: 10.21608/bfsa.2022.239464. IncludeDE_KQ2 Record ID 24913 [CrossRef]

132.

Duda M, Haber N, Daniels J, et al. Crowdsourced validation of a machine-learning classification system for autism and ADHD. Transl Psychiatry. 2017 May 16;7(5):e1133. doi: 10.1038/tp.2017.86. PMID: 28509905. IncludeDE_KQ1 Record ID 1604 [PMC free article: PMC5534954] [PubMed: 28509905] [CrossRef]

133.

Duda M, Ma R, Haber N, et al. Use of machine learning for behavioral distinction of autism and ADHD. Transl Psychiatry. 2016 Feb 9;6(2):e732. doi: 10.1038/tp.2015.221. PMID: 26859815. IncludeDE_KQ1 Record ID 12880 [PMC free article: PMC4872425] [PubMed: 26859815] [CrossRef]

134.

Duke University, National Institute of Mental Health. Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study). 2009a. IncludeDE_KQ2_Study 1 to ID 28649 Record ID 13823

135.

Duke University, National Institute of Mental Health. Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study). 2009b. IncludeDE_KQ2_Study 2 to ID 13823 Record ID 28649

136.

DuPaul GJ, Anastopoulos AD, Shelton TL, et al. Multimethod assessment of attention-deficit hyperactivity disorder: The diagnostic utility of clinic-based tests. Journal of Clinical Child Psychology. 1992;21(4):394–402. doi: 10.1207/s15374424jccp2104_10. IncludeDE_KQ1 Record ID 27284 [CrossRef]

137.

DuPaul GJ, Evans SW, Owens JS, et al. School-based intervention for adolescents with attention-deficit/hyperactivity disorder: Effects on academic functioning. J Sch Psychol. 2021 Aug;87:48–63. doi: 10.1016/j.jsp.2021.07.001. PMID: 34303447. IncludeDE_KQ2 Record ID 4227 [PubMed: 34303447] [CrossRef]

138.

Durgut E, Orengul AC, Algun ZC. Comparison of the effects of treadmill and vibration training in children with attention deficit hyperactivity disorder: A randomized controlled trial. NeuroRehabilitation. 2020;47(2):121–31. doi: 10.3233/nre-203040. PMID: 32741784. IncludeDE_KQ2 Record ID 338 [PubMed: 32741784] [CrossRef]

139.

Duric NS, Assmus J, Gundersen D, et al. Multimodal treatment in children and adolescents with attention-deficit/hyperactivity disorder: a 6-month follow-up. Nord J Psychiatry. 2017 Jul;71(5):386–94. doi: 10.1080/08039488.2017.1305446. PMID: 28345387. IncludeDE_KQ2 Record ID 271 [PubMed: 28345387] [CrossRef]

140.

Ebesutani C, Bernstein A, Nakamura BJ, et al. Concurrent Validity of the Child Behavior Checklist DSM-Oriented Scales: Correspondence with DSM Diagnoses and Comparison to Syndrome Scales. J Psychopathol Behav Assess. 2010 Sep;32(3):373–84. doi: 10.1007/s10862-009-9174-9. PMID: 20700377. IncludeDE_KQ1 Record ID 27343 [PMC free article: PMC2914253] [PubMed: 20700377] [CrossRef]

141.

Edwards MC, Sigel BA. Estimates of the utility of Child Behavior Checklist/Teacher Report Form Attention Problems scale in the diagnosis of ADHD in children referred to a specialty clinic. Journal of Psychopathology and Behavioral Assessment. 2015;37:50–9. doi: 10.1007/s10862-014-9431-4. IncludeDE_KQ1 Record ID 24276 [CrossRef]

142.

Egeland J AA, Saunes BK. Few effects of far transfer of working memory training in ADHD: a randomized controlled trial. PLoS One. 2013;8(10):e75660. doi: 10.1371/journal.pone.0075660. IncludeDE_KQ2 Record ID 17026 [PMC free article: PMC3790857] [PubMed: 24124503] [CrossRef]

143.

Eiraldi RB, Power TJ, Karustis JL, et al. Assessing ADHD and comorbid disorders in children: the Child Behavior Checklist and the Devereux Scales of Mental Disorders. J Clin Child Psychol. 2000 Mar;29(1):3–16. doi: 10.1207/S15374424jccp2901_2. PMID: 10693028. IncludeDE_KQ1 Record ID 24277 [PubMed: 10693028] [CrossRef]

144.

Ekhlasi A, Nasrabadi AM, Mohammadi M. Analysis of EEG brain connectivity of children with ADHD using graph theory and directional information transfer. Biomed Tech (Berl). 2022 Oct 6;68(2):133–46. doi: 10.1515/bmt-2022-0100. PMID: 36197950. IncludeDE_KQ1 Record ID 23972 [PubMed: 36197950] [CrossRef]

145.

El-Sayed E, van’t Hooft I, Fried I, et al. Measurements of attention deficits and impulsivity: a Swedish study of the Gordon Diagnostic System. Acta Paediatr. 1999 Nov;88(11):1262–8. doi: 10.1080/080352599750030400. PMID: 10591431. IncludeDE_KQ1 Record ID 22741 [PubMed: 10591431] [CrossRef]

146.

Eli Lilly Company. An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). 2004. IncludeDE_KQ2 Record ID 13893

147.

Eli Lilly Company. Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany. 2006. IncludeDE_KQ2 Record ID 13928

148.

Eli Lilly Company. Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD). 2007. IncludeDE_KQ2 Record ID 13894

149.

Eli Lilly Company. Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD). 2008. IncludeDE_KQ2 Record ID 13749

150.

Elkins RM, Carpenter AL, Pincus DB, et al. Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder. J Anxiety Disord. 2014 Dec;28(8):754–60. doi: 10.1016/j.janxdis.2014.09.003. PMID: 25260213. IncludeDE_KQ1 Record ID 24673 [PMC free article: PMC4252769] [PubMed: 25260213] [CrossRef]

151.

Elmaadawi AZ, Patel R, Almaaitah Y, et al. Effect of pharmacogenomic testing on pediatric mental health outcome: a 6-month follow-up. Pharmacogenomics. 2022 Dec 5. doi: 10.2217/pgs-2022-0131. PMID: 36468359. IncludeDE_KQ2 Record ID 23890 [PubMed: 36468359] [CrossRef]

152.

Emser TS, Johnston BA, Steele JD, et al. Assessing ADHD symptoms in children and adults: evaluating the role of objective measures. Behav Brain Funct. 2018 May 18;14(1):11. doi: 10.1186/s12993-018-0143-x. PMID: 29776429. IncludeDE_KQ1 Record ID 1605 [PMC free article: PMC5960089] [PubMed: 29776429] [CrossRef]

153.

Enns JE, Randall JR, Smith M, et al. A Multimodal Intervention for Children with ADHD Reduces Inequity in Health and Education Outcomes. Can J Psychiatry. 2017 Jun;62(6):403–12. doi: 10.1177/0706743717692301. PMID: 28146649. IncludeDE_KQ2 Record ID 1921 [PMC free article: PMC5455871] [PubMed: 28146649] [CrossRef]

154.

Epstein JN, Kelleher KJ, Baum R, et al. Impact of a Web-Portal Intervention on Community ADHD Care and Outcomes. Pediatrics. 2016 Aug;138(2). doi: 10.1542/peds.2015-4240. PMID: 27462065. IncludeDE_KQ2_IncludeDE_KQ3 Record ID 13678 [PMC free article: PMC4960725] [PubMed: 27462065] [CrossRef]

155.

Epstein JN, Rabiner D, Johnson DE, et al. Improving attention-deficit/hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: a cluster randomized trial. Arch Pediatr Adolesc Med. 2007 Sep;161(9):835–40. doi: 10.1001/archpedi.161.9.835. PMID: 17768282. IncludeDE_KQ2_IncludeDE_KQ3 Record ID 14442 [PubMed: 17768282] [CrossRef]

156.

Ercan ES, Ardic UA, Kutlu A, et al. No beneficial effects of adding parent training to methylphenidate treatment for ADHD + ODD/CD children: a 1-year prospective follow-up study. J Atten Disord. 2014 Feb;18(2):145–57. doi: 10.1177/1087054711432884. PMID: 22522574. IncludeDE_KQ2 Record ID 14296 [PubMed: 22522574] [CrossRef]

157.

Estrada-Plana V, Esquerda M, Mangues R, et al. A Pilot Study of the Efficacy of a Cognitive Training Based on Board Games in Children with Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. Games Health J. 2019 Aug;8(4):265–74. doi: 10.1089/g4h.2018.0051. PMID: 30653355. IncludeDE_KQ2 Record ID 422 [PubMed: 30653355] [CrossRef]

158.

Evans SW, Langberg JM, Schultz BK, et al. Evaluation of a school-based treatment program for young adolescents with ADHD. J Consult Clin Psychol. 2016 Jan;84(1):15–30. doi: 10.1037/ccp0000057. PMID: 26501496. IncludeDE_KQ2 Record ID 12901 [PubMed: 26501496] [CrossRef]

159.

F. C. New marker using bioimpedance technology in screening for attention deficit/hyperactivity disorder (ADHD) in children as an adjunct to conventional diagnostic methods. Psychol Res Behav Manag. 2011;4:113–7. doi: 10.2147/prbm.s22924. IncludeDE_KQ1 Record ID 17014 [PMC free article: PMC3218780] [PubMed: 22114541] [CrossRef]

160.

Fabiano GA, Schatz NK, Morris KL, et al. Efficacy of a family-focused intervention for young drivers with attention-deficit hyperactivity disorder. J Consult Clin Psychol. 2016 Dec;84(12):1078–93. doi: 10.1037/ccp0000137. PMID: 27618640. IncludeDE_KQ2 Record ID 1868 [PMC free article: PMC5125890] [PubMed: 27618640] [CrossRef]

161.

Fallah R, Eiliaei S, Ferdosian F. Clinical Trial of Efficacy Evaluation of Omega-3 with Risperidone on Seizures Frequency in Children with Refractory Epilepsy and Attention-Deficit/Hyperactivity Disorder. Iran J Child Neurol. 2018 Fall;12(4):28–36. PMID: 30279706. IncludeDE_KQ2 Record ID 4252 [PMC free article: PMC6160632] [PubMed: 30279706]

162.

Faraone SV, Newcorn JH, Antshel KM, et al. The Groundskeeper Gaming Platform as a Diagnostic Tool for Attention-Deficit/Hyperactivity Disorder: Sensitivity, Specificity, and Relation to Other Measures. J Child Adolesc Psychopharmacol. 2016 Oct;26(8):672–85. doi: 10.1089/cap.2015.0174. PMID: 27105181. IncludeDE_KQ1 Record ID 12909 [PMC free article: PMC5069710] [PubMed: 27105181] [CrossRef]

163.

Farmer CA, Epstein JN, Findling RL, et al. Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory. J Child Adolesc Psychopharmacol. 2017 Mar;27(2):117–24. doi: 10.1089/cap.2016.0040. PMID: 27348211. IncludeDE_KQ2 Record ID 525 [PMC free article: PMC5367910] [PubMed: 27348211] [CrossRef]

164.

Ferrin M, Moreno-Granados JM, Salcedo-Marin MD, et al. Evaluation of a psychoeducation programme for parents of children and adolescents with ADHD: immediate and long-term effects using a blind randomized controlled trial. Eur Child Adolesc Psychiatry. 2014 Aug;23(8):637–47. doi: 10.1007/s00787-013-0494-7. PMID: 24292412. IncludeDE_KQ2 Record ID 14215 [PubMed: 24292412] [CrossRef]

165.

Ferrin M, Perez-Ayala V, El-Abd S, et al. A Randomized Controlled Trial Evaluating the Efficacy of a Psychoeducation Program for Families of Children and Adolescents With ADHD in the United Kingdom: Results After a 6-Month Follow-Up. J Atten Disord. 2020 Mar;24(5):768–79. doi: 10.1177/1087054715626509. PMID: 26838557. IncludeDE_KQ2 Record ID 4267 [PubMed: 26838557] [CrossRef]

166.

Ferrin M VA. Examination of neurological subtle signs in ADHD as a clinical tool for the diagnosis and their relationship to spatial working memory. J Child Psychol Psychiatry. 2012 Apr;53(4):390–400. doi: 10.1111/j.1469-7610.2011.02496.x. PMID: 22141455. IncludeDE_KQ1 Record ID 17004 [PubMed: 22141455] [CrossRef]

167.

Fiks AG, Mayne SL, Michel JJ, et al. Distance-Learning, ADHD Quality Improvement in Primary Care: A Cluster-Randomized Trial. J Dev Behav Pediatr. 2017 Oct;38(8):573–83. doi: 10.1097/dbp.0000000000000490. PMID: 28816912. IncludeDE_KQ3 Record ID 341 [PMC free article: PMC5657444] [PubMed: 28816912] [CrossRef]

168.

Findling RL, Adler LA, Spencer TJ, et al. Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial. J Child Adolesc Psychopharmacol. 2019 Mar;29(2):80–9. doi: 10.1089/cap.2018.0083. PMID: 30694697. IncludeDE_KQ2 Record ID 310 [PubMed: 30694697] [CrossRef]

169.

Findling RL, Childress AC, Cutler AJ, et al. Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011 Apr;50(4):395–405. doi: 10.1016/j.jaac.2011.01.007. PMID: 21421179. IncludeDE_KQ2 Record ID 17155 [PubMed: 21421179] [CrossRef]

170.

Findling RL, Short EJ, Manos MJ. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2001 Dec;40(12):1441–7. doi: 10.1097/00004583-200112000-00015. PMID: 11765290. IncludeDE_KQ2 Record ID 17990 [PubMed: 11765290] [CrossRef]

171.

Findling RL, Turnbow J, Burnside J, et al. A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescents. CNS Spectr. 2010 Jul;15(7):419–30. doi: 10.1017/s1092852900000353. PMID: 20625364. IncludeDE_KQ2 Record ID 17270 [PubMed: 20625364] [CrossRef]

172.

Findling RL BO, Melmed RD, López FA, Sallee FR, Arnold LE, Pratt RD. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2008 Jan;69(1):149–59. doi: 10.4088/jcp.v69n0120. PMID: 18312050. IncludeDE_KQ2 Record ID 19232 [PubMed: 18312050] [CrossRef]

173.

Florida International University. Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth. 2010. https://clinicaltrials.gov/ct2/show/NCT01109849. Accessed on October 11 2022. IncludeDE_KQ3 Record ID 22379

174.

Florida International University. Intervention for Teens With ADHD and Substance Use. 2015. IncludeDE_KQ2 Record ID 27087

175.

Forbes GB. Clinical utility of the Test of Variables of Attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder. J Clin Psychol. 1998 Jun;54(4):461–76. doi: 10.1002/(sici)1097-4679(199806)54:4<461::aid-jclp8>3.0.co;2-q. PMID: 9623751. IncludeDE_KQ1 Record ID 27286 [PubMed: 9623751] [CrossRef]

176.

François-Sévigny J, Pilon M, Gauthier LA. Differences in Parents and Teachers’ Perceptions of Behavior Manifested by Gifted Children with ADHD Compared to Gifted Children without ADHD and Non-Gifted Children with ADHD Using the Conners 3 Scale. Brain Sci. 2022 Nov 18;12(11). doi: 10.3390/brainsci12111571. PMID: 36421895. IncludeDE_KQ1 Record ID 24089 [PMC free article: PMC9688281] [PubMed: 36421895] [CrossRef]

177.

Frei H, Everts R, von Ammon K, et al. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial. Eur J Pediatr. 2005 Dec;164(12):758–67. doi: 10.1007/s00431-005-1735-7. PMID: 16047154. IncludeDE_KQ2 Record ID 14253 [PubMed: 16047154] [CrossRef]

178.

Frei H, Thurneysen A. Treatment for hyperactive children: homeopathy and methylphenidate compared in a family setting. Br Homeopath J. 2001 Oct;90(4):183–8. doi: 10.1054/homp.1999.0506. PMID: 11680802. IncludeDE_KQ2 Record ID 17988 [PubMed: 11680802] [CrossRef]

179.

Fuchs T, Birbaumer N, Lutzenberger W, et al. Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: a comparison with methylphenidate. Appl Psychophysiol Biofeedback. 2003 Mar;28(1):1–12. doi: 10.1023/a:1022353731579. PMID: 12737092. IncludeDE_KQ2 Record ID 27142 [PubMed: 12737092] [CrossRef]

180.

Fuentes J, Danckaerts M, Cardo E, et al. Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2013 Dec;33(6):766–74. doi: 10.1097/JCP.0b013e31829c762b. PMID: 23963057. IncludeDE_KQ2 Record ID 14733 [PubMed: 23963057] [CrossRef]

181.

Gao MS, Tsai FS, Lee CC. Learning a Phenotypic-Attribute Attentional Brain Connectivity Embedding for ADHD Classification using rs-fMRI. Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5472–5. doi: 10.1109/embc44109.2020.9175789. PMID: 33019218. IncludeDE_KQ1 Record ID 1752 [PubMed: 33019218] [CrossRef]

182.

Garcia-Argibay M, Zhang-James Y, Cortese S, et al. Predicting childhood and adolescent attention-deficit/hyperactivity disorder onset: a nationwide deep learning approach. Mol Psychiatry. 2022 Dec 19. doi: 10.1038/s41380-022-01918-8. PMID: 36536075. IncludeDE_KQ1 Record ID 23900 [PMC free article: PMC10005952] [PubMed: 36536075] [CrossRef]

183.

García-Sánchez C, Estévez-González A, Suárez-Romero E, et al. Right hemisphere dysfunction in subjects with attention-deficit disorder with and without hyperactivity. J Child Neurol. 1997 Feb;12(2):107–15. doi: 10.1177/088307389701200207. PMID: 9075020. IncludeDE_KQ1 Record ID 22842 [PubMed: 9075020] [CrossRef]

184.

Gardner W, Lucas A, Kolko DJ, et al. Comparison of the PSC-17 and alternative mental health screens in an at-risk primary care sample. J Am Acad Child Adolesc Psychiatry. 2007 May;46(5):611–8. doi: 10.1097/chi.0b013e318032384b. PMID: 17450052. IncludeDE_KQ1 Record ID 22843 [PubMed: 17450052] [CrossRef]

185.

Garg J, Arun P, Chavan BS. Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder. Indian Pediatr. 2014 Jul;51(7):550–4. doi: 10.1007/s13312-014-0445-5. PMID: 25031133. IncludeDE_KQ2 Record ID 24360 [PubMed: 25031133] [CrossRef]

186.

Gargaro BA, May T, Tonge BJ, et al. Using the DBC-P Hyperactivity Index to screen for ADHD in young people with autism and ADHD: A pilot study. Research in Autism Spectrum Disorders. 2014 2014/09/01/;8(9):1008–15. doi: 10.1016/j.rasd.2014.05.004. IncludeDE_KQ1 Record ID 24679 [CrossRef]

187.

Gau SS, Huang YS, Soong WT, et al. A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007 Aug;17(4):447–60. doi: 10.1089/cap.2006.0091. PMID: 17822340. IncludeDE_KQ2 Record ID 17568 [PubMed: 17822340] [CrossRef]

188.

Gau SS, Shen HY, Soong WT, et al. An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Child Adolesc Psychopharmacol. 2006 Aug;16(4):441–55. doi: 10.1089/cap.2006.16.441. PMID: 16958569. IncludeDE_KQ2 Record ID 17668 [PubMed: 16958569] [CrossRef]

189.

Geissler JM, Vloet TD, Strom N, et al. Does helping mothers in multigenerational ADHD also help children in the long run? 2-year follow-up from baseline of the AIMAC randomized controlled multicentre trial. Eur Child Adolesc Psychiatry. 2020 Oct;29(10):1425–39. doi: 10.1007/s00787-019-01451-0. PMID: 31807943. IncludeDE_KQ2 Record ID 3445 [PubMed: 31807943] [CrossRef]

190.

Geladé K, Bink M, Janssen TW, et al. An RCT into the effects of neurofeedback on neurocognitive functioning compared to stimulant medication and physical activity in children with ADHD. Eur Child Adolesc Psychiatry. 2017 Apr;26(4):457–68. doi: 10.1007/s00787-016-0902-x. PMID: 27665293. IncludeDE_KQ2 Record ID 4319 [PMC free article: PMC5364239] [PubMed: 27665293] [CrossRef]

191.

Geller D, Donnelly C, Lopez F, et al. Atomoxetine Treatment for Pediatric Patients with Attention-Deficit/Hyperactivity Disorder with Comorbid Anxiety Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 2007 09/01/;46(9):1119-S. doi: 10.1097/chi.0b013e3180ca8385. PMID: 17712235. IncludeDE_KQ2 Record ID 18394 [PubMed: 17712235] [CrossRef]

192.

Geurts HM, Verté S, Oosterlaan J, et al. How specific are executive functioning deficits in attention deficit hyperactivity disorder and autism? J Child Psychol Psychiatry. 2004 May;45(4):836–54. doi: 10.1111/j.1469-7610.2004.00276.x. PMID: 15056314. IncludeDE_KQ1 Record ID 24543 [PubMed: 15056314] [CrossRef]

193.

Gevensleben H HB, Albrecht B, et al. Neurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trial. Eur Child Adolesc Psychiatry. 2010 Sep;19(9):715–24. doi: 10.1007/s00787-010-0109-5. IncludeDE_KQ2 Record ID 17058 [PMC free article: PMC3128749] [PubMed: 20499120] [CrossRef]

194.

Ghajar A, Aghajan-Nashtaei F, Afarideh M, et al. l-Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Child Adolesc Psychopharmacol. 2018 Jun;28(5):331–8. doi: 10.1089/cap.2017.0157. PMID: 29469593. IncludeDE_KQ2 Record ID 448 [PubMed: 29469593] [CrossRef]

195.

Ghanizadeh A, Haddad B. The effect of dietary education on ADHD, a randomized controlled clinical trial. Ann Gen Psychiatry. 2015;14:12. doi: 10.1186/s12991-015-0050-6. PMID: 25767556. IncludeDE_KQ2 Record ID 27204 [PMC free article: PMC4357187] [PubMed: 25767556] [CrossRef]

196.

Gibbons RD, Kupfer DJ, Frank E, et al. Computerized Adaptive Tests for Rapid and Accurate Assessment of Psychopathology Dimensions in Youth. J Am Acad Child Adolesc Psychiatry. 2020 Nov;59(11):1264–73. doi: 10.1016/j.jaac.2019.08.009. PMID: 31465832. IncludeDE_KQ1 Record ID 2914 [PMC free article: PMC7042076] [PubMed: 31465832] [CrossRef]

197.

Gilbert H, Qin L, Li D, et al. Aiding the diagnosis of AD/HD in childhood: Using actigraphy and a continuous performance test to objectively quantify symptoms. Res Dev Disabil. 2016 Dec;59:35–42. doi: 10.1016/j.ridd.2016.07.013. PMID: 27497372. IncludeDE_KQ1 Record ID 906 [PubMed: 27497372] [CrossRef]

198.

Goh PK, Elkins AR, Bansal PS, et al. Data-Driven Methods for Predicting ADHD Diagnosis and Related Impairment: The Potential of a Machine Learning Approach. Res Child Adolesc Psychopathol. 2023 Jan 19. doi: 10.1007/s10802-023-01022-7. PMID: 36656406. IncludeDE_KQ1 Record ID 25980 [PubMed: 36656406] [CrossRef]

199.

Gomez R, Vance A, Stavropoulos V. Test-Retest Measurement Invariance of Clinic Referred Children’s ADHD Symptoms. Journal of Psychopathology and Behavioral Assessment. 2018;40(2):194–205. doi: 10.1007/s10862-017-9636-4. IncludeDE_KQ1 Record ID 7526 [CrossRef]

200.

Gomez R, Vance A, Watson S, et al. ROC Analyses of Relevant Conners 3-Short Forms, CBCL, and TRF Scales for Screening ADHD and ODD. Assessment. 2021 Jan;28(1):73–85. doi: 10.1177/1073191119876023. PMID: 31535569. IncludeDE_KQ1 Record ID 668 [PubMed: 31535569] [CrossRef]

201.

González-Castro P, Cueli M, Rodríguez C, et al. Efficacy of Neurofeedback Versus Pharmacological Support in Subjects with ADHD. Appl Psychophysiol Biofeedback. 2016 Mar;41(1):17–25. doi: 10.1007/s10484-015-9299-4. PMID: 26290167. IncludeDE_KQ2 Record ID 12954 [PubMed: 26290167] [CrossRef]

202.

Grazioli S, Crippa A, Rosi E, et al. Exploring telediagnostic procedures in child neuropsychiatry: addressing ADHD diagnosis and autism symptoms through supervised machine learning. Eur Child Adolesc Psychiatry. 2023 Jan 25:1–11. doi: 10.1007/s00787-023-02145-4. PMID: 36695897. IncludeDE_KQ1 Record ID 25987 [PMC free article: PMC9875192] [PubMed: 36695897] [CrossRef]

203.

Greenhill LL, Biederman J, Boellner SW, et al. A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):503–11. doi: 10.1097/01.chi.0000205709.63571.c9. PMID: 16601402. IncludeDE_KQ2 Record ID 17666 [PubMed: 16601402] [CrossRef]

204.

Greenhill LL, Muniz R, Ball RR, et al. Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):817–23. doi: 10.1097/01.chi.0000220847.41027.5d. PMID: 16832318. IncludeDE_KQ2 Record ID 17665 [PubMed: 16832318] [CrossRef]

205.

Griffiths KR, Leikauf JE, Tsang TW, et al. Response inhibition and emotional cognition improved by atomoxetine in children and adolescents with ADHD: The ACTION randomized controlled trial. J Psychiatr Res. 2018 Jul;102:57–64. doi: 10.1016/j.jpsychires.2018.03.009. PMID: 29674270. IncludeDE_KQ2 Record ID 477 [PMC free article: PMC9148271] [PubMed: 29674270] [CrossRef]

206.

Grodzinsky GM, Diamond R. Frontal lobe functioning in boys with attention-deficit hyperactivity disorder. Developmental Neuropsychology. 1992 1992/01/01;8(4):427–45. doi: 10.1080/87565649209540536. IncludeDE_KQ1 Record ID 24546 [CrossRef]

207.

Guevara JP, Power TJ, Bevans K, et al. Improving Care Management in Attention-Deficit/Hyperactivity Disorder: An RCT. Pediatrics. 2021 Aug;148(2). doi: 10.1542/peds.2020-031518. PMID: 34281997. IncludeDE_KQ2 Record ID 3262 [PubMed: 34281997] [CrossRef]

208.

Gungor M, Kurutas EB, Oner E, et al. Diagnostic performance of erythropoietin and erythropoietin receptors levels in children with attention deficit hyperactivity disorder. Clinical Psychopharmacology and Neuroscience. 2021;19(3):530–6. doi: 10.9758/cpn.2021.19.3.530. IncludeDE_KQ1 Record ID 7609 [PMC free article: PMC8316662] [PubMed: 34294622] [CrossRef]

209.

Gustafsson PA B-TU, Duchen K, et al. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatr. 2010 Oct;99(10):1540–9. doi: 10.1111/j.1651-2227.2010.01871.x. PMID: 20491709. IncludeDE_KQ2 Record ID 17028 [PubMed: 20491709] [CrossRef]

210.

Guttentag S, Bishop S, Doggett R, et al. The Utility of Parent-Report Screening Tools in Differentiating Autism versus Attention-Deficit/Hyperactivity Disorder in School-Age Children. Autism: The International Journal of Research and Practice. 2022 02/01/;26(2):473–87. PMID: EJ1327733. IncludeDE_KQ1 Record ID 27681 [PubMed: 34219504]

211.

Häger LA, Åsberg Johnels J, Kropotov JD, et al. Biomarker support for ADHD diagnosis based on Event Related Potentials and scores from an attention test. Psychiatry Res. 2021 Jun;300:113879. doi: 10.1016/j.psychres.2021.113879. PMID: 33882399. IncludeDE_KQ1 Record ID 3618 [PubMed: 33882399] [CrossRef]

212.

Hahn-Markowitz J, Berger I, Manor I, et al. Efficacy of Cognitive-Functional (Cog-Fun) Occupational Therapy Intervention Among Children With ADHD: An RCT. J Atten Disord. 2020 Mar;24(5):655–66. doi: 10.1177/1087054716666955. PMID: 27637735. IncludeDE_KQ2 Record ID 5578 [PubMed: 27637735] [CrossRef]

213.

Hall CL, Guo B, Valentine AZ, et al. The Validity of the SNAP-IV in Children Displaying ADHD Symptoms. Assessment. 2020 Sep;27(6):1258–71. doi: 10.1177/1073191119842255. PMID: 30991820. IncludeDE_KQ1 Record ID 554 [PubMed: 30991820] [CrossRef]

214.

Hall CL, Selby K, Guo B, et al. Innovations in Practice: an objective measure of attention, impulsivity and activity reduces time to confirm attention deficit/hyperactivity disorder diagnosis in children – a completed audit cycle. Child and Adolescent Mental Health. 2016;21(3):175–8. doi: 10.1111/camh.12140. IncludeDE_KQ1 Record ID 7651 [PubMed: 32680350] [CrossRef]

215.

Hamadache S, Hoberg K, Zaplana Labarga S, et al. Is the QbMini a Valid Instrument for ADHD Assessment? J Atten Disord. 2021 Aug;25(10):1384–94. doi: 10.1177/1087054720903361. PMID: 32075486. IncludeDE_KQ1 Record ID 28653 [PubMed: 32075486] [CrossRef]

216.

Harfterkamp M, van de Loo-Neus G, Minderaa RB, et al. A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):733–41. doi: 10.1016/j.jaac.2012.04.011. PMID: 22721596. IncludeDE_KQ2 Record ID 24399 [PubMed: 22721596] [CrossRef]

217.

Hariri M DA, Djalali M, et al. Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder. Malays J Nutr. 2012 Dec;18(3):329–35. PMID: 24568073. IncludeDE_KQ2 Record ID 17029 [PubMed: 24568073]

218.

Hasaneen BM, Sarhan M, Samir S, et al. T2∗ magnetic resonance imaging: A non-invasive biomarker of brain iron content in children with attention-deficit/hyperactivity disorder. Egyptian Journal of Radiology and Nuclear Medicine. 2017;48(1):161–7. doi: 10.1016/j.ejrnm.2016.08.001. IncludeDE_KQ1 Record ID 7691 [CrossRef]

219.

Hasslinger J, Bölte S, Jonsson U. Slow Cortical Potential Versus Live Z-score Neurofeedback in Children and Adolescents with ADHD: A Multi-arm Pragmatic Randomized Controlled Trial with Active and Passive Comparators. Res Child Adolesc Psychopathol. 2021 Sep 3. doi: 10.1007/s10802-021-00858-1. PMID: 34478006. IncludeDE_KQ2 Record ID 13002 [PMC free article: PMC8940855] [PubMed: 34478006] [CrossRef]

220.

Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry. 2003 Aug;42(8):886–94. doi: 10.1097/01.Chi.0000046908.27264.00. PMID: 12874489. IncludeDE_KQ2 Record ID 14216 [PubMed: 12874489] [CrossRef]

221.

Helgadóttir H, Gudmundsson Ó, Baldursson G, et al. Electroencephalography as a clinical tool for diagnosing and monitoring attention deficit hyperactivity disorder: a cross-sectional study. BMJ Open. 2015 Jan 16;5(1):e005500. doi: 10.1136/bmjopen-2014-005500. PMID: 25596195. IncludeDE_KQ1 Record ID 14201 [PMC free article: PMC4298102] [PubMed: 25596195] [CrossRef]

222.

Heller MD, Roots K, Srivastava S, et al. A Machine Learning-Based Analysis of Game Data for Attention Deficit Hyperactivity Disorder Assessment. Games Health J. 2013 Oct;2(5):291–8. doi: 10.1089/g4h.2013.0058. PMID: 26196929. IncludeDE_KQ1 Record ID 24338 [PubMed: 26196929] [CrossRef]

223.

Hemamy M, Pahlavani N, Amanollahi A, et al. The effect of vitamin D and magnesium supplementation on the mental health status of attention-deficit hyperactive children: a randomized controlled trial. BMC Pediatr. 2021 Apr 17;21(1):178. doi: 10.1186/s12887-021-02631-1. PMID: 33865361. IncludeDE_KQ2 Record ID 511 [PMC free article: PMC8052751] [PubMed: 33865361] [CrossRef]

224.

Herbert SD, Harvey EA, Roberts JL, et al. A randomized controlled trial of a parent training and emotion socialization program for families of hyperactive preschool-aged children. Behav Ther. 2013 Jun;44(2):302–16. doi: 10.1016/j.beth.2012.10.004. PMID: 23611079. IncludeDE_KQ2 Record ID 24388 [PubMed: 23611079] [CrossRef]

225.

Hervas A, Huss M, Johnson M, et al. Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial. Eur Neuropsychopharmacol. 2014 Dec;24(12):1861–72. doi: 10.1016/j.euroneuro.2014.09.014. PMID: 25453486. IncludeDE_KQ2 Record ID 19229 [PubMed: 25453486] [CrossRef]

226.

Hinshaw SP, Carte ET, Sami N, et al. Preadolescent girls with attention-deficit/hyperactivity disorder: II. Neuropsychological performance in relation to subtypes and individual classification. J Consult Clin Psychol. 2002 Oct;70(5):1099–111. doi: 10.1037//0022-006x.70.5.1099. PMID: 12362960. IncludeDE_KQ1 Record ID 24547 [PubMed: 12362960] [CrossRef]

227.

Hirayama S, Terasawa K, Rabeler R, et al. The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial. J Hum Nutr Diet. 2014 Apr;27 Suppl 2:284–91. doi: 10.1111/jhn.12090. PMID: 23495677. IncludeDE_KQ2 Record ID 24381 [PubMed: 23495677] [CrossRef]

228.

Hiscock H, Mulraney M, Heussler H, et al. Impact of a behavioral intervention, delivered by pediatricians or psychologists, on sleep problems in children with ADHD: a cluster-randomized, translational trial. J Child Psychol Psychiatry. 2019 Nov;60(11):1230–41. doi: 10.1111/jcpp.13083. PMID: 31184382. IncludeDE_KQ2 Record ID 433 [PubMed: 31184382] [CrossRef]

229.

Hogue A, Horan Fisher J, Dauber S, et al. Randomized Trial of Academic Training and Medication Decision-Making for Adolescents with ADHD in Usual Care. J Clin Child Adolesc Psychol. 2020 Feb 20:1–14. doi: 10.1080/15374416.2020.1716362. PMID: 32078394. IncludeDE_KQ2 Record ID 4409 [PMC free article: PMC7438261] [PubMed: 32078394] [CrossRef]

230.

Hong N, Comer JS. High-End Specificity of the Attention-Deficit/Hyperactivity Problems Scale of the Child Behavior Checklist for Ages 1.5-5 in a Sample of Young Children with Disruptive Behavior Disorders. Child Psychiatry Hum Dev. 2019 Apr;50(2):222–9. doi: 10.1007/s10578-018-0834-4. PMID: 30056520. IncludeDE_KQ1 Record ID 911 [PubMed: 30056520] [CrossRef]

231.

Hong SS, Cho SH. Treating attention deficit hyperactivity disorder with acupuncture: A randomized controlled trial. European Journal of Integrative Medicine. 2016;8(3):150–7. doi: 10.1016/j.eujim.2015.11.018. IncludeDE_KQ2 Record ID 7764 [CrossRef]

232.

Hosainzadeh Maleki Z, Mashhadi A, Soltanifar A, et al. Barkley’s Parent Training Program, Working Memory Training and their Combination for Children with ADHD: Attention Deficit Hyperactivity Disorder. Iran J Psychiatry. 2014 Apr;9(2):47–54. PMID: 25632280. IncludeDE_KQ2 Record ID 27386 [PMC free article: PMC4300465] [PubMed: 25632280]

233.

Huang XX, Ou P, Qian QF, et al. Long-term effectiveness of behavioural intervention in preschool children with attention deficit hyperactivity disorder in Southeast China – a randomized controlled trial. BMC Pediatrics. 2021;21(1). doi: 10.1186/s12887-021-03046-8. IncludeDE_KQ2 Record ID 7795 [CrossRef]

234.

Huang YH CC, Ou HY, et al. Treatment effects of combining social skill training and parent training in Taiwanese children with attention deficit hyperactivity disorder. Journal of the Formosan Medical Association. 2015;114(3):260–7. IncludeDE_KQ2 Record ID 17030 [PubMed: 25777975]

235.

Hudziak JJ, Copeland W, Stanger C, et al. Screening for DSM-IV externalizing disorders with the Child Behavior Checklist: a receiver-operating characteristic analysis. J Child Psychol Psychiatry. 2004 Oct;45(7):1299–307. doi: 10.1111/j.1469-7610.2004.00314.x. PMID: 15335349. IncludeDE_KQ1 Record ID 22972 [PubMed: 15335349] [CrossRef]

236.

Hult N, Kadesjö J, Kadesjö B, et al. ADHD and the QbTest: Diagnostic Validity of QbTest. Journal of Attention Disorders. 2018 Sep;22(11):1074–80. doi: 10.1177/1087054715595697. PMID: 26224575. IncludeDE_KQ1 Record ID 14 [PubMed: 26224575] [CrossRef]

237.

Ichikawa H, Miyajima T, Yamashita Y, et al. Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2020 Feb;30(1):21–31. doi: 10.1089/cap.2019.0076. PMID: 31718254. IncludeDE_KQ2 Record ID 330 [PMC free article: PMC7041327] [PubMed: 31718254] [CrossRef]

238.

Ickowicz A, Schachar RJ, Sugarman R, et al. The parent interview for child symptoms: a situation-specific clinical research interview for attention-deficit hyperactivity and related disorders. Can J Psychiatry. 2006 Apr;51(5):325–8. doi: 10.1177/070674370605100508. PMID: 16986822. IncludeDE_KQ1 Record ID 22985 [PubMed: 16986822] [CrossRef]

239.

Jacobson LA, Pritchard AE, Koriakin TA, et al. Initial Examination of the BRIEF2 in Clinically Referred Children With and Without ADHD Symptoms. J Atten Disord. 2020 Oct;24(12):1775–84. doi: 10.1177/1087054716663632. PMID: 27519529. IncludeDE_KQ1 Record ID 1419 [PMC free article: PMC5303680] [PubMed: 27519529] [CrossRef]

240.

Jahanshahloo HR, Shamsi M, Ghasemi E, et al. Automated and ERP-Based Diagnosis of Attention-Deficit Hyperactivity Disorder in Children. J Med Signals Sens. 2017 Jan–Mar;7(1):26–32. PMID: 28487830. IncludeDE_KQ1 Record ID 3313 [PMC free article: PMC5394803] [PubMed: 28487830]

241.

Jain R, Segal S, Kollins SH, et al. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011 Feb;50(2):171–9. doi: 10.1016/j.jaac.2010.11.005. PMID: 21241954. IncludeDE_KQ2 Record ID 17129 [PubMed: 21241954] [CrossRef]

242.

Jarrett MA, Meter AV, Youngstrom EA, et al. Evidence-Based Assessment of ADHD in Youth Using a Receiver Operating Characteristic Approach. J Clin Child Adolesc Psychol. 2018 Sep–Oct;47(5):808–20. doi: 10.1080/15374416.2016.1225502. PMID: 27775429. IncludeDE_KQ1 Record ID 725 [PubMed: 27775429] [CrossRef]

243.

Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):989–1002. doi: 10.1097/CHI.0b013e3180686d48. PMID: 17667478. IncludeDE_KQ2 Record ID 16987 [PubMed: 17667478] [CrossRef]

244.

Jensen-Doss A, Osterberg LD, Hickey JS, et al. Agreement between chart diagnoses and standardized instrument ratings of youth psychopathology. Adm Policy Ment Health. 2013 Sep;40(5):428–37. doi: 10.1007/s10488-012-0436-6. PMID: 22918708. IncludeDE_KQ1 Record ID 27346 [PubMed: 22918708] [CrossRef]

245.

Ji H, Wu S, Won J, et al. The Effects of Exergaming on Attention in Children With Attention Deficit/Hyperactivity Disorder: Randomized Controlled Trial. JMIR Serious Games. 2023 May 9;11:e40438. doi: 10.2196/40438. PMID: 37159253. IncludeDE_KQ2 Record ID 28299 [PMC free article: PMC10206614] [PubMed: 37159253] [CrossRef]

246.

Jiménez-Figueroa G, Ardila-Duarte C, Pineda DA, et al. Prepotent response inhibition and reaction times in children with attention deficit/hyperactivity disorder from a Caribbean community. Atten Defic Hyperact Disord. 2017 Dec;9(4):199–211. doi: 10.1007/s12402-017-0223-z. PMID: 28238028. IncludeDE_KQ1 Record ID 1065 [PubMed: 28238028] [CrossRef]

247.

Johansson V, Noren Selinus E, Kuja-Halkola R, et al. The Quantified Behavioral Test Failed to Differentiate ADHD in Adolescents With Neurodevelopmental Problems. J Atten Disord. 2021 Feb;25(3):312–21. doi: 10.1177/1087054718787034. PMID: 30024318. IncludeDE_KQ1 Record ID 28654 [PubMed: 30024318] [CrossRef]

248.

Johnson JK, Liranso T, Saylor K, et al. A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD. J Atten Disord. 2020 Jan;24(2):348–58. doi: 10.1177/1087054719836159. PMID: 30924702. IncludeDE_KQ2 Record ID 272 [PMC free article: PMC6939319] [PubMed: 30924702] [CrossRef]

249.

Johnson M OS, Fransson G, et al. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents. J Atten Disord. 2009 Mar;12(5):394–401. doi: 10.1177/1087054708316261. PMID: 18448859. IncludeDE_KQ2 Record ID 17031 [PubMed: 18448859] [CrossRef]

250.

Johnstone JM, Hatsu I, Tost G, et al. Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial. J Am Acad Child Adolesc Psychiatry. 2022 May;61(5):647–61. doi: 10.1016/j.jaac.2021.07.005. PMID: 34303786. IncludeDE_KQ2 Record ID 18993 [PMC free article: PMC8782920] [PubMed: 34303786] [CrossRef]

251.

Johnstone SJ, Parrish L, Jiang H, et al. Aiding diagnosis of childhood attention-deficit/hyperactivity disorder of the inattentive presentation: Discriminant function analysis of multi-domain measures including EEG. Biol Psychol. 2021 Apr;161:108080. doi: 10.1016/j.biopsycho.2021.108080. PMID: 33744372. IncludeDE_KQ1 Record ID 1010 [PubMed: 33744372] [CrossRef]

252.

Juneja M, Mehar H, Sairam S, et al. Children’s Color Trail Test for Objective Assessment of Attention in Children with Attention Deficit Hyperactivity Disorder: A Diagnostic Accuracy Study. Indian Pediatr. 2019 Dec 15;56(12):1025–8. PMID: 31884432. IncludeDE_KQ1 Record ID 826 [PubMed: 31884432]

253.

Kadri A, Slimani M, Bragazzi NL, et al. Effect of Taekwondo Practice on Cognitive Function in Adolescents with Attention Deficit Hyperactivity Disorder. Int J Environ Res Public Health. 2019 Jan 12;16(2). doi: 10.3390/ijerph16020204. PMID: 30642062. IncludeDE_KQ2 Record ID 267 [PMC free article: PMC6352161] [PubMed: 30642062] [CrossRef]

254.

Kahbazi M, Ghoreishi A, Rahiminejad F, et al. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Res. 2009 Aug 15;168(3):234–7. doi: 10.1016/j.psychres.2008.06.024. PMID: 19439364. IncludeDE_KQ2 Record ID 17364 [PubMed: 19439364] [CrossRef]

255.

Kam HJ, Shin YM, Cho SM, et al. Development of a Decision Support Model for Screening Attention-deficit Hyperactivity Disorder with Actigraph-based Measurements of Classroom Activity. Appl Clin Inform. 2010;1(4):377–93. doi: 10.4338/ACI-2010-05-RA-0033. PMID: 23616848. IncludeDE_KQ1 Record ID 27433 [PMC free article: PMC3633315] [PubMed: 23616848] [CrossRef]

256.

Karabiber Cura O, Kocaaslan Atli S, Akan A. Attention deficit hyperactivity disorder recognition based on intrinsic time-scale decomposition of EEG signals. Biomedical Signal Processing and Control. 2023;81. doi: 10.1016/j.bspc.2022.104512. IncludeDE_KQ1 Record ID 25087 [CrossRef]

257.

Karakaya D, Özgür G. Effect of a Solution-Focused Approach on Self-Efficacy and Self-Esteem in Turkish Adolescents With Attention-Deficit/Hyperactivity Disorder. J Psychosoc Nurs Ment Health Serv. 2019 Nov 1;57(11):45–55. doi: 10.3928/02793695-20190708-01. PMID: 31305949. IncludeDE_KQ2 Record ID 339 [PubMed: 31305949] [CrossRef]

258.

Kareem MEA, Latef SAA, Rafaatamin O. Impact of intervention program on attention of Attention Deficit Hyperactivity Children (ADHD). Pakistan Journal of Medical and Health Sciences. 2021;15(1):407–11. IncludeDE_KQ2 Record ID 8017

259.

Karr JE, Kibby MY, Jagger-Rickels AC, et al. Sensitivity and Specificity of an Executive Function Screener at Identifying Children With ADHD and Reading Disability. J Atten Disord. 2021 Jan;25(1):134–40. doi: 10.1177/1087054718763878. PMID: 29562850. IncludeDE_KQ1 Record ID 1099 [PMC free article: PMC6146073] [PubMed: 29562850] [CrossRef]

260.

Katz M LA, Kol-Degani H, et al. A compound herbal preparation (CHP) in the treatment of children with ADHD: a randomized controlled trial. J Atten Disord. 2010 Nov;14(3):281–91. doi: 10.1177/1087054709356388. PMID: 20228219. IncludeDE_KQ2 Record ID 17032 [PubMed: 20228219] [CrossRef]

261.

Kelsey DK, Sumner CR, Casat CD, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics. 2004 Jul;114(1):e1–8. doi: 10.1542/peds.114.1.e1. PMID: 15231966. IncludeDE_KQ2 Record ID 24395 [PubMed: 15231966] [CrossRef]

262.

Kennerley S, Jaquiery B, Hatch B, et al. Informant discrepancies in the assessment of attention-deficit/hyperactivity disorder. Journal of Psychoeducational Assessment. 2018 Mar 2018;36(2):136–47. IncludeDE_KQ1 Record ID 11675

263.

Khaksarian M, Ahangari N, Masjedi-Arani A, et al. A comparison of methylphenidate (MPH) and combined methylphenidate with crocus sativus (saffron) in the treatment of children and adolescents with ADHD: A randomized, double-blind, parallel-group, clinical trial. Iranian Journal of Psychiatry and Behavioral Sciences. 2021;15(3). doi: 10.5812/IJPBS.108390. IncludeDE_KQ2 Record ID 8049 [CrossRef]

264.

Khoshbakht Y, Moghtaderi F, Bidaki R, et al. The effect of dietary approaches to stop hypertension (DASH) diet on attention-deficit hyperactivity disorder (ADHD) symptoms: a randomized controlled clinical trial. Eur J Nutr. 2021 Mar 14. doi: 10.1007/s00394-021-02527-x. PMID: 33715085. IncludeDE_KQ2 Record ID 3097 [PubMed: 33715085] [CrossRef]

265.

Kim J LY, Han D, et al. The utility of quantitative electroencephalography and Integrated Visual and Auditory Continuous Performance Test as auxiliary tools for the Attention Deficit Hyperactivity Disorder diagnosis. Clin Neurophysiol. 2015;126(3):532–40. doi: 10.1016/j.clinph.2014.06.034. IncludeDE_KQ1 Record ID 17006 [PubMed: 25088931] [CrossRef]

266.

Kim JW LJ, Kim BN, et al. Theta-phase gamma-amplitude coupling as a neurophysiological marker of attention deficit/hyperactivity disorder in children. Neurosci Lett. 2015 Aug 31;603:25–30. doi: 10.1016/j.neulet.2015.07.006. IncludeDE_KQ1 Record ID 17005 [PubMed: 26170246] [CrossRef]

267.

Kim SC, Lee H, Lee HS, et al. Adjuvant Therapy for Attention in Children with ADHD Using Game-Type Digital Therapy. Int J Environ Res Public Health. 2022 Nov 14;19(22). doi: 10.3390/ijerph192214982. PMID: 36429699. IncludeDE_KQ2 Record ID 26139 [PMC free article: PMC9690113] [PubMed: 36429699] [CrossRef]

268.

Kofler MJ, Wells EL, Singh LJ, et al. A randomized controlled trial of central executive training (CET) versus inhibitory control training (ICT) for ADHD. J Consult Clin Psychol. 2020 Aug;88(8):738–56. doi: 10.1037/ccp0000550. PMID: 32700955. IncludeDE_KQ2 Record ID 4524 [PMC free article: PMC7384295] [PubMed: 32700955] [CrossRef]

269.

Koh JEW, Ooi CP, Lim-Ashworth NS, et al. Automated classification of attention deficit hyperactivity disorder and conduct disorder using entropy features with ECG signals. Comput Biol Med. 2021 Dec 4;140:105120. doi: 10.1016/j.compbiomed.2021.105120. PMID: 34896884. IncludeDE_KQ1 Record ID 27648 [PubMed: 34896884] [CrossRef]

270.

Koh JEW, Ooi CP, Lim-Ashworth NS, et al. Automated classification of attention deficit hyperactivity disorder and conduct disorder using entropy features with ECG signals. Computers in Biology and Medicine. 2022;140. doi: 10.1016/j.compbiomed.2021.105120. IncludeDE_KQ1 Record ID 8128 [CrossRef]

271.

Kolko DJ, Hart JA, Campo J, et al. Effects of Collaborative Care for Comorbid Attention Deficit Hyperactivity Disorder Among Children With Behavior Problems in Pediatric Primary Care. Clin Pediatr (Phila). 2020 Jul;59(8):787–800. doi: 10.1177/0009922820920013. PMID: 32503395. IncludeDE_KQ2 Record ID 332 [PMC free article: PMC7444430] [PubMed: 32503395] [CrossRef]

272.

Kollins SH, DeLoss DJ, Cañadas E, et al. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. Lancet Digit Health. 2020 Apr;2(4):e168–e78. doi: 10.1016/s2589-7500(20)30017-0. PMID: 33334505. IncludeDE_KQ2 Record ID 265 [PubMed: 33334505] [CrossRef]

273.

Kollins SH, Jain R, Brams M, et al. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics. 2011 Jun;127(6):e1406–13. doi: 10.1542/peds.2010-1260. PMID: 21555501. IncludeDE_KQ2 Record ID 17125 [PMC free article: PMC3387872] [PubMed: 21555501] [CrossRef]

274.

Kollins SH, López FA, Vince BD, et al. Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Apr;21(2):111–20. doi: 10.1089/cap.2010.0064. PMID: 21476931. IncludeDE_KQ2 Record ID 17124 [PubMed: 21476931] [CrossRef]

275.

Korfmacher AK, Hirsch O, Chavanon ML, et al. Self-management training vs. neurofeedback interventions for attention deficit hyperactivity disorder: Results of a randomized controlled treatment study. Front Psychiatry. 2022;13:969351. doi: 10.3389/fpsyt.2022.969351. PMID: 36061275. IncludeDE_KQ2 Record ID 24047 [PMC free article: PMC9433654] [PubMed: 36061275] [CrossRef]

276.

Kratochvil CJ, Heiligenstein JH, Dittmann R, et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry. 2002 Jul;41(7):776–84. doi: 10.1097/00004583-200207000-00008. PMID: 12108801. IncludeDE_KQ2 Record ID 17937 [PubMed: 12108801] [CrossRef]

277.

Kratochvil CJ, Newcorn JH, Arnold LE, et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry. 2005 Sep;44(9):915–24. doi: 10.1097/01.chi.0000169012.81536.38. PMID: 16113620. IncludeDE_KQ2 Record ID 17757 [PubMed: 16113620] [CrossRef]

278.

Kratochvil CJ VB, Stoner JA, Daughton JM, Lubberstedt BD, Murray DW, Chrisman AK, Faircloth MA, Itchon-Ramos NB, Kollins SH, Maayan LA, Greenhill LL, Kotler LA, Fried J, March JS. A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics. 2011 Apr;127(4):e862–8. doi: 10.1542/peds.2010-0825. PMID: 21422081. IncludeDE_KQ2 Record ID 19239 [PMC free article: PMC3387889] [PubMed: 21422081] [CrossRef]

279.

Krieger V, Amador-Campos JA. Clinical presentations of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents: comparison of neurocognitive performance. Child Neuropsychol. 2021 Apr 30:1–30. doi: 10.1080/09297049.2021.1917530. PMID: 33928840. IncludeDE_KQ1 Record ID 3268 [PubMed: 33928840] [CrossRef]

280.

Kurlan R, Goetz CG, McDermott MP, et al. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002a Feb 26;58(4):527–36. doi: 10.1212/wnl.58.4.527. PMID: 11865128. IncludeDE_KQ2_Study 1 to ID 28648 Record ID 17966 [PubMed: 11865128] [CrossRef]

281.

Kurlan R, Goetz CG, McDermott MP, et al. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002b Feb 26;58(4):527–36. doi: 10.1212/wnl.58.4.527. PMID: 11865128. IncludeDE_KQ2_Study 2 to ID 17966 Record ID 28648 [PubMed: 11865128] [CrossRef]

282.

Kurokami T, Kobayashi H, Nakajima M, et al. Establishment of an objective index for the diagnosis of attention deficit/hyperactivity disorder by the continuous performance test “MOGRAZ”. Brain Dev. 2022 Nov;44(10):664–71. doi: 10.1016/j.braindev.2022.07.002. PMID: 35879141. IncludeDE_KQ1 Record ID 26163 [PubMed: 35879141] [CrossRef]

283.

Kurowski BG, Epstein JN, Pruitt DW, et al. Benefits of Methylphenidate for Long-Term Attention Problems After Traumatic Brain Injury in Childhood: A Randomized, Double-Masked, Placebo-Controlled, Dose-Titration, Crossover Trial. J Head Trauma Rehabil. 2019 Mar/Apr;34(2):E1–e12. doi: 10.1097/htr.0000000000000432. PMID: 30169436. IncludeDE_KQ2 Record ID 415 [PMC free article: PMC6395577] [PubMed: 30169436] [CrossRef]

284.

Lange AM, Daley D, Frydenberg M, et al. Parent Training for Preschool ADHD in Routine, Specialist Care: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry. 2018 Aug;57(8):593–602. doi: 10.1016/j.jaac.2018.04.014. PMID: 30071980. IncludeDE_KQ2 Record ID 363 [PubMed: 30071980] [CrossRef]

285.

Lau C, Stewart SL, Saklofske DH, et al. Psychometric Evaluation of the interRAI Child and Youth Mental Health Disruptive/Aggression Behaviour Scale (DABS) and Hyperactive/Distraction Scale (HDS). Child Psychiatry Hum Dev. 2018 Apr;49(2):279–89. doi: 10.1007/s10578-017-0751-y. PMID: 28791517. IncludeDE_KQ1 Record ID 27350 [PubMed: 28791517] [CrossRef]

286.

Lavigne JV, Dulcan MK, LeBailly SA, et al. Computer-assisted management of attention-deficit/hyperactivity disorder. Pediatrics. 2011 Jul;128(1):e46–53. doi: 10.1542/peds.2010-2684. PMID: 21669891. IncludeDE_KQ2 Record ID 14409 [PMC free article: PMC3124100] [PubMed: 21669891] [CrossRef]

287.

Law SF SR. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry. 1999;38(8):944–51. IncludeDE_KQ2 Record ID 18308 [PubMed: 10434485]

288.

Lee W, Lee D, Lee S, et al. Deep-Learning-Based ADHD Classification Using Children’s Skeleton Data Acquired through the ADHD Screening Game. Sensors (Basel). 2022 Dec 26;23(1). doi: 10.3390/s23010246. PMID: 36616844. IncludeDE_KQ1 Record ID 26197 [PMC free article: PMC9824773] [PubMed: 36616844] [CrossRef]

289.

Lefler EK, Hartung CM, Fedele DA. Psychometric properties of a primary care mental health screening tool for young children. Children’s Health Care. 2012;41(2):79–96. doi: 10.1080/02739615.2012.657058. IncludeDE_KQ1 Record ID 27351 [CrossRef]

290.

Lesica S, Skeel R, Fust B. The parent-reported ADHD symptom infrequency scale (PRASIS): a parent report measure of ADHD symptom exaggeration. Child Neuropsychol. 2023 Feb;29(2):255–75. doi: 10.1080/09297049.2022.2081676. PMID: 35618325. IncludeDE_KQ1 Record ID 26207 [PubMed: 35618325] [CrossRef]

291.

Levy JD, Kronenberger WG, Dunn DW. Development of a Very Brief Measure of ADHD: The CHAOS Scale. J Atten Disord. 2017 May;21(7):575–86. doi: 10.1177/1087054713497792. PMID: 23995051. IncludeDE_KQ1 Record ID 869 [PubMed: 23995051] [CrossRef]

292.

Li D, Guo J. Intervention Effect of Theme Building Block Games on the Mental Health and Behavior of Children with Attention Deficit Hyperactivity Disorder. Psychiatr Danub. 2022 Winter;34(4):660–7. doi: 10.24869/psyd.2022.660. PMID: 36548878. IncludeDE_KQ2 Record ID 26215 [PubMed: 36548878] [CrossRef]

293.

Li F, Zheng Y, Smith SD, et al. A preliminary study of movement intensity during a Go/No-Go task and its association with ADHD outcomes and symptom severity. Child and Adolescent Psychiatry and Mental Health. 2016;10(1). doi: 10.1186/s13034-016-0135-2. IncludeDE_KQ1 Record ID 8307 [CrossRef]

294.

Li W, Zhou T, Zou L, et al. Identification of attention deficit/hyperactivity disorder in children using multiple ERP features. Current Bioinformatics. 2018;13(5):501–7. doi: 10.2174/1574893612666171201142836. IncludeDE_KQ1 Record ID 8315 [CrossRef]

295.

Li YL, Tang YQ, Liu B, et al. Electroencephalogram diagnosis and biofeedback treatment for the child with attention deficit hyperactivity disorder. Chinese Journal of Clinical Rehabilitation. 2005;9(8):236–7. IncludeDE_KQ1 Record ID 18719

296.

Liang X, Qiu H, Wang P, et al. The impacts of a combined exercise on executive function in children with ADHD: A randomized controlled trial. Scand J Med Sci Sports. 2022 Aug;32(8):1297–312. doi: 10.1111/sms.14192. PMID: 35611615. IncludeDE_KQ2 Record ID 26222 [PubMed: 35611615] [CrossRef]

297.

Liechti MD VL, Muller UC, et al. Diagnostic value of resting electroencephalogram in attention-deficit/hyperactivity disorder across the lifespan. Brain Topogr. 2013 Jan;26(1):135–51. doi: 10.1007/s10548-012-0258-6. IncludeDE_KQ1 Record ID 17008 [PubMed: 23053601] [CrossRef]

298.

Lim CG, Poh XWW, Fung SSD, et al. A randomized controlled trial of a brain-computer interface based attention training program for ADHD. PLoS One. 2019;14(5):e0216225. doi: 10.1371/journal.pone.0216225. PMID: 31112554. IncludeDE_KQ2 Record ID 322 [PMC free article: PMC6528992] [PubMed: 31112554] [CrossRef]

299.

Lin DY, Kratochvil CJ, Xu W, et al. A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014 May;24(4):190–200. doi: 10.1089/cap.2013.0043. PMID: 24840045. IncludeDE_KQ2 Record ID 19269 [PMC free article: PMC4026219] [PubMed: 24840045] [CrossRef]

300.

Lin H, Haider SP, Kaltenhauser S, et al. Population level multimodal neuroimaging correlates of attention-deficit hyperactivity disorder among children. Front Neurosci. 2023;17:1138670. doi: 10.3389/fnins.2023.1138670. PMID: 36908780. IncludeDE_KQ1 Record ID 26228 [PMC free article: PMC9992191] [PubMed: 36908780] [CrossRef]

301.

Lin HY. The Effect of Spatial Uncertainty on Visual Search in Older School-Aged Children with and without ADHD. Arch Clin Neuropsychol. 2023 Jan 30. doi: 10.1093/arclin/acad003. PMID: 36715611. IncludeDE_KQ1 Record ID 26229 [PubMed: 36715611] [CrossRef]

302.

Lin IC, Chang SC, Huang YJ, et al. Distinguishing different types of attention deficit hyperactivity disorder in children using artificial neural network with clinical intelligent test. Front Psychol. 2022;13:1067771. doi: 10.3389/fpsyg.2022.1067771. PMID: 36710799. IncludeDE_KQ1 Record ID 26230 [PMC free article: PMC9875079] [PubMed: 36710799] [CrossRef]

303.

Lindhiem O, Goel M, Shaaban S, et al. Objective Measurement of Hyperactivity Using Mobile Sensing and Machine Learning: Pilot Study. JMIR Form Res. 2022 Apr 25;6(4):e35803. doi: 10.2196/35803. PMID: 35468089. IncludeDE_KQ1 Record ID 23917 [PMC free article: PMC9086887] [PubMed: 35468089] [CrossRef]

304.

Liu X, Sun L, Zhang D, et al. Phase-Amplitude Coupling Brain Networks in Children with Attention-Deficit/Hyperactivity Disorder. Clin EEG Neurosci. 2022 Sep;53(5):399–405. doi: 10.1177/15500594221086195. PMID: 35257602. IncludeDE_KQ1 Record ID 26242 [PubMed: 35257602] [CrossRef]

305.

Longridge R, Norman S, Henley W, et al. Investigating the agreement between the clinician and research diagnosis of attention deficit hyperactivity disorder and how it changes over time; a clinical cohort study. Child Adolesc Ment Health. 2019 May;24(2):133–41. doi: 10.1111/camh.12285. PMID: 32677186. IncludeDE_KQ1 Record ID 3191 [PubMed: 32677186] [CrossRef]

306.

Ludyga S, Mücke M, Leuenberger R, et al. Behavioral and neurocognitive effects of judo training on working memory capacity in children with ADHD: A randomized controlled trial. Neuroimage Clin. 2022;36:103156. doi: 10.1016/j.nicl.2022.103156. PMID: 35988343. IncludeDE_KQ2 Record ID 26256 [PMC free article: PMC9402389] [PubMed: 35988343] [CrossRef]

307.

Luo J, Huang H, Wang S, et al. A Wearable Diagnostic Assessment System vs. SNAP-IV for the auxiliary diagnosis of ADHD: a diagnostic test. BMC Psychiatry. 2022 Jun 21;22(1):415. doi: 10.1186/s12888-022-04038-3. PMID: 35729503. IncludeDE_KQ1 Record ID 26258 [PMC free article: PMC9214968] [PubMed: 35729503] [CrossRef]

308.

Luo N, Luo X, Zheng S, et al. Aberrant brain dynamics and spectral power in children with ADHD and its subtypes. Eur Child Adolesc Psychiatry. 2022 Aug 22. doi: 10.1007/s00787-022-02068-6. PMID: 35996018. IncludeDE_KQ1 Record ID 23935 [PMC free article: PMC10576687] [PubMed: 35996018] [CrossRef]

309.

Luo X, Guo X, Zhao Q, et al. A randomized controlled study of remote computerized cognitive, neurofeedback, and combined training in the treatment of children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2022 Feb 19:1–12. doi: 10.1007/s00787-022-01956-1. PMID: 35182242. IncludeDE_KQ2 Record ID 24092 [PMC free article: PMC8857637] [PubMed: 35182242] [CrossRef]

310.

Lv YB, Cheng W, Wang MH, et al. Effect of non-pharmacological treatment on the full recovery of social functioning in patients with attention deficit hyperactivity disorder. World Journal of Clinical Cases. 2023;11(14):3238–47. doi: 10.12998/wjcc.v11.i14.3238. IncludeDE_KQ2 Record ID 28325 [PMC free article: PMC10237121] [PubMed: 37274030] [CrossRef]

311.

Manor I, Magen A, Keidar D, et al. The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension. Eur Psychiatry. 2012 Jul;27(5):335–42. doi: 10.1016/j.eurpsy.2011.05.004. PMID: 21807480. IncludeDE_KQ2 Record ID 14854 [PubMed: 21807480] [CrossRef]

312.

Marcano JL, Bell MA, Beex AAL. Classification of ADHD and non-ADHD subjects using a universal background model. Biomedical Signal Processing and Control. 2018;39:204–12. doi: 10.1016/j.bspc.2017.07.023. IncludeDE_KQ1 Record ID 8454 [PMC free article: PMC6557459] [PubMed: 31186670] [CrossRef]

313.

Markovska-Simoska S, Pop-Jordanova N. Quantitative EEG in Children and Adults With Attention Deficit Hyperactivity Disorder: Comparison of Absolute and Relative Power Spectra and Theta/Beta Ratio. Clin EEG Neurosci. 2017 Jan;48(1):20–32. doi: 10.1177/1550059416643824. PMID: 27170672. IncludeDE_KQ1 Record ID 1284 [PubMed: 27170672] [CrossRef]

314.

Martenyi F, Zavadenko NN, Jarkova NB, et al. Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia. Eur Child Adolesc Psychiatry. 2010 Jan;19(1):57–66. doi: 10.1007/s00787-009-0042-7. PMID: 19568826. IncludeDE_KQ2 Record ID 17245 [PubMed: 19568826] [CrossRef]

315.

Martín-Brufau R, Nombela Gómez M. Bioelectrical Markers of ADHD: Enhancement of Direct EEG Analysis. Electronic Journal of Research in Educational Psychology. 2017 04/01/;15(1):185–200. PMID: EJ1136431. IncludeDE_KQ1 Record ID 10843

316.

Martin-Martinez D C-d-l-HP, Alberola-Lopez S, et al. Nonlinear analysis of actigraphic signals for the assessment of the attention-deficit/hyperactivity disorder (ADHD). Med Eng Phys. 2012 Nov;34(9):1317–29. doi: 10.1016/j.medengphy.2011.12.023. IncludeDE_KQ1 Record ID 17009 [PubMed: 22297088] [CrossRef]

317.

Matier-Sharma K, Perachio N, Newcorn JH, et al. Differential diagnosis of ADHD: Are objective measures of attention, impulsivity, and activity level helpful? Child Neuropsychology. 1995;1(2):118–27. doi: 10.1080/09297049508402243. IncludeDE_KQ1 Record ID 27216 [CrossRef]

318.

Matthijssen AM, Dietrich A, Bierens M, et al. Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study. Am J Psychiatry. 2019 Sep 1;176(9):754–62. doi: 10.1176/appi.ajp.2019.18111296. PMID: 31109200. IncludeDE_KQ2 Record ID 289 [PubMed: 31109200] [CrossRef]

319.

Mattingly G, Arnold V, Yan B, et al. A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2020 Nov;30(9):549–57. doi: 10.1089/cap.2020.0005. PMID: 33185468. IncludeDE_KQ2 Record ID 3060 [PMC free article: PMC7698843] [PubMed: 33185468] [CrossRef]

320.

Maya-Piedrahita MC, Herrera-Gomez PM, Berrío-Mesa L, et al. Supported Diagnosis of Attention Deficit and Hyperactivity Disorder from EEG Based on Interpretable Kernels for Hidden Markov Models. Int J Neural Syst. 2022 Mar;32(3):2250008. doi: 10.1142/s0129065722500083. PMID: 34996341. IncludeDE_KQ1 Record ID 26293 [PubMed: 34996341] [CrossRef]

321.

Mayes SD, Calhoun SL. The Gordon Diagnostic System and WISC-III Freedom from Distractibility Index: validity in identifying clinic-referred children with and without ADHD. Psychol Rep. 2002 Oct;91(2):575–87. doi: 10.2466/pr0.2002.91.2.575. PMID: 12416852. IncludeDE_KQ1 Record ID 27290 [PubMed: 12416852] [CrossRef]

322.

Mayes SD, Calhoun SL. Similarities and differences in Wechsler Intelligence Scale for Children--Third Edition (WISC-III) profiles: support for subtest analysis in clinical referrals. Clin Neuropsychol. 2004 Dec;18(4):559–72. doi: 10.1080/13854040490888530. PMID: 15841957. IncludeDE_KQ1 Record ID 23240 [PubMed: 15841957] [CrossRef]

323.

Mayfield AR, Parke EM, Barchard KA, et al. Equivalence of mother and father ratings of ADHD in children. Child Neuropsychology. 2018 Feb 2018;24(2):166–83. doi: 10.1080/09297049.2016.1236186. PMID: 27729001. IncludeDE_KQ1 Record ID 11911 [PubMed: 27729001] [CrossRef]

324.

McCarthy A, Asghar S, Wilens T, et al. Using a Brief Parent-Report Measure to Track Outcomes for Children and Teens with ADHD. Child Psychiatry Hum Dev. 2016 Jun;47(3):407–16. doi: 10.1007/s10578-015-0575-6. PMID: 26271346. IncludeDE_KQ1 Record ID 13196 [PubMed: 26271346] [CrossRef]

325.

McCracken JT, McGough JJ, Loo SK, et al. Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):657–66.e1. doi: 10.1016/j.jaac.2016.05.015. PMID: 27453079. IncludeDE_KQ2 Record ID 13198 [PMC free article: PMC4976782] [PubMed: 27453079] [CrossRef]

326.

McGrath PJ L-PP, Thurston C, MacLean C, Cunningham C, Waschbusch DA, Watters C, Stewart S, Bagnell A, Santor D, Chaplin W. Telephone-based mental health interventions for child disruptive behavior or anxiety disorders: randomized trials and overall analysis. J Am Acad Child Adolesc Psychiatry. 2011 Nov;50(11):1162–72. doi: 10.1016/j.jaac.2011.07.013. PMID: 22024004. IncludeDE_KQ2 Record ID 19244 [PubMed: 22024004] [CrossRef]

327.

McIntosh DE, Mulkins RS, Dean RS. Utilization of maternal perinatal risk indicators in the differential diagnosis of ADHD and UADD children. Int J Neurosci. 1995 Mar;81(1–2):35–46. doi: 10.3109/00207459509015297. PMID: 7775071. IncludeDE_KQ1 Record ID 23263 [PubMed: 7775071] [CrossRef]

328.

Mehri M, Chehrzad MM, Mardani A, et al. The effect of behavioral parent training on sleep problems of school-age children with ADHD: A parallel randomized controlled trial. Arch Psychiatr Nurs. 2020 Aug;34(4):261–7. doi: 10.1016/j.apnu.2020.04.001. PMID: 32828358. IncludeDE_KQ2 Record ID 342 [PubMed: 32828358] [CrossRef]

329.

Merzon L, Pettersson K, Aronen ET, et al. Eye movement behavior in a real-world virtual reality task reveals ADHD in children. Sci Rep. 2022 Nov 24;12(1):20308. doi: 10.1038/s41598-022-24552-4. PMID: 36434040. IncludeDE_KQ1 Record ID 26318 [PMC free article: PMC9700686] [PubMed: 36434040] [CrossRef]

330.

Meyer J, Ramklint M, Hallerbäck MU, et al. Evaluation of a structured skills training group for adolescents with attention-deficit/hyperactivity disorder: a randomised controlled trial. Eur Child Adolesc Psychiatry. 2021 Mar 15. doi: 10.1007/s00787-021-01753-2. PMID: 33721085. IncludeDE_KQ2 Record ID 3212 [PMC free article: PMC9343260] [PubMed: 33721085] [CrossRef]

331.

Michelson D, Allen AJ, Busner J, et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry. 2002 Nov;159(11):1896–901. doi: 10.1176/appi.ajp.159.11.1896. PMID: 12411225. IncludeDE_KQ2 Record ID 17933 [PubMed: 12411225] [CrossRef]

332.

Michelson D, Faries D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001 Nov;108(5):E83. doi: 10.1542/peds.108.5.e83. PMID: 11694667. IncludeDE_KQ2 Record ID 17979 [PubMed: 11694667] [CrossRef]

333.

Mikami AY, Griggs MS, Lerner MD, et al. A randomized trial of a classroom intervention to increase peers’ social inclusion of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2013 Feb;81(1):100–12. doi: 10.1037/a0029654. PMID: 22866680. IncludeDE_KQ2 Record ID 27130 [PMC free article: PMC3522754] [PubMed: 22866680] [CrossRef]

334.

Mikolas P, Vahid A, Bernardoni F, et al. Training a machine learning classifier to identify ADHD based on real-world clinical data from medical records. Sci Rep. 2022 Jul 28;12(1):12934. doi: 10.1038/s41598-022-17126-x. PMID: 35902654. IncludeDE_KQ1 Record ID 26331 [PMC free article: PMC9334289] [PubMed: 35902654] [CrossRef]

335.

Minder F, Zuberer A, Brandeis D, et al. Informant-related effects of neurofeedback and cognitive training in children with ADHD including a waiting control phase: a randomized-controlled trial. Eur Child Adolesc Psychiatry. 2018 Aug;27(8):1055–66. doi: 10.1007/s00787-018-1116-1. PMID: 29396712. IncludeDE_KQ2 Record ID 4689 [PubMed: 29396712] [CrossRef]

336.

Mitchell WG, Chavez JM, Baker SA, et al. Reaction time, impulsivity, and attention in hyperactive children and controls: a video game technique. J Child Neurol. 1990 Jul;5(3):195–204. doi: 10.1177/088307389000500308. PMID: 2398235. IncludeDE_KQ1 Record ID 24339 [PubMed: 2398235] [CrossRef]

337.

Miyahara M, Healey DM, Halperin JM. One-week temporal stability of hyperactivity in preschoolers with ADHD during psychometric assessment. Psychiatry Clin Neurosci. 2014 Feb;68(2):120–6. doi: 10.1111/pcn.12096. PMID: 24552632. IncludeDE_KQ1 Record ID 27435 [PMC free article: PMC3930929] [PubMed: 24552632] [CrossRef]

338.

Moghaddari M, Lighvan MZ, Danishvar S. Diagnose ADHD disorder in children using convolutional neural network based on continuous mental task EEG. Comput Methods Programs Biomed. 2020 Dec;197:105738. doi: 10.1016/j.cmpb.2020.105738. PMID: 32927404. IncludeDE_KQ1 Record ID 1537 [PubMed: 32927404] [CrossRef]

339.

Mohammadi MR, Kazemi MR, Zia E, et al. Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial. Hum Psychopharmacol. 2010 Nov;25(7–8):560–5. doi: 10.1002/hup.1154. PMID: 21312290. IncludeDE_KQ2 Record ID 17236 [PubMed: 21312290] [CrossRef]

340.

Mohammadi MR MS, Keshavarz SA, et al. Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial. Iran J Psychiatry. 2012 Spring;7(2):87–92. IncludeDE_KQ2 Record ID 17034 [PMC free article: PMC3428643] [PubMed: 22952551]

341.

Mohammadzadeh S, Baghi N, Yousefi F, et al. Effect of omega-3 plus methylphenidate as an alternative therapy to reduce attention deficit-hyperactivity disorder in children. Korean J Pediatr. 2019 Sep;62(9):360–6. doi: 10.3345/kjp.2018.06982. PMID: 31122010. IncludeDE_KQ2 Record ID 2986 [PMC free article: PMC6753311] [PubMed: 31122010] [CrossRef]

342.

Montoya A, Hervas A, Cardo E, et al. Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder. Curr Med Res Opin. 2009 Nov;25(11):2745–54. doi: 10.1185/03007990903316152. PMID: 19785510. IncludeDE_KQ2 Record ID 17348 [PubMed: 19785510] [CrossRef]

343.

Mostajeran Z, Mosavat SH, Najafi M, et al. Whey Protein (Ma’aljobon) as a Complementary Therapy for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD): A Randomized Open-label Controlled Clinical Trial. Galen Med J. 2020;9:e1690. doi: 10.31661/gmj.v9i0.1690. PMID: 34466569. IncludeDE_KQ2 Record ID 13229 [PMC free article: PMC8343698] [PubMed: 34466569] [CrossRef]

344.

Motaharifard MS, Effatpanah M, Karimi M, et al. Effect of sweet almond syrup versus methylphenidate in children with ADHD: A randomized triple-blind clinical trial. Complement Ther Clin Pract. 2019 Aug;36:170–5. doi: 10.1016/j.ctcp.2019.07.008. PMID: 31383435. IncludeDE_KQ2 Record ID 354 [PubMed: 31383435] [CrossRef]

345.

Moura O, Costa P, Simões MR. WISC-III Cognitive Profiles in Children with ADHD: Specific Cognitive Impairments and Diagnostic Utility. J Gen Psychol. 2019 Jul–Sep;146(3):258–82. doi: 10.1080/00221309.2018.1561410. PMID: 30729871. IncludeDE_KQ1 Record ID 2409 [PubMed: 30729871] [CrossRef]

346.

Moura O, Pereira M, Alfaiate C, et al. Neurocognitive functioning in children with developmental dyslexia and attention-deficit/hyperactivity disorder: Multiple deficits and diagnostic accuracy. J Clin Exp Neuropsychol. 2017 Apr;39(3):296–312. doi: 10.1080/13803395.2016.1225007. PMID: 27617883. IncludeDE_KQ1 Record ID 2189 [PubMed: 27617883] [CrossRef]

347.

Mouti A, Dryer R, Kohn M. Differentiating Autism Spectrum Disorder From ADHD Using the Social Communication Questionnaire. J Atten Disord. 2019 Jun;23(8):828–37. doi: 10.1177/1087054718781945. PMID: 29936891. IncludeDE_KQ1 Record ID 707 [PubMed: 29936891] [CrossRef]

348.

Mulhern S, Dworkin PH, Bernstein B. Do parental concerns predict a diagnosis of attention-deficit hyperactivity disorder? J Dev Behav Pediatr. 1994 Oct;15(5):348–52. PMID: 7868703. IncludeDE_KQ1 Record ID 18130 [PubMed: 7868703]

349.

Muthuraman M, Moliadze V, Boecher L, et al. Multimodal alterations of directed connectivity profiles in patients with attention-deficit/hyperactivity disorders. Sci Rep. 2019 Dec 27;9(1):20028. doi: 10.1038/s41598-019-56398-8. PMID: 31882672. IncludeDE_KQ1 Record ID 2272 [PMC free article: PMC6934806] [PubMed: 31882672] [CrossRef]

350.

Mwamba HM, Fourie PR, den Heever DV. PANDAS: Paediatric Attention-Deficit/Hyperactivity Disorder Application Software. Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:1444–7. doi: 10.1109/embc.2019.8857357. PMID: 31946165. IncludeDE_KQ1 Record ID 1908 [PubMed: 31946165] [CrossRef]

351.

Myers K VSA, Zhou C, et al. Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):263–74. doi: 10.1016/j.jaac.2015.01.009. IncludeDE_KQ2 Record ID 17050 [PMC free article: PMC4406418] [PubMed: 25791143] [CrossRef]

352.

Nasser A, Liranso T, Adewole T, et al. A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder. J Clin Psychopharmacol. 2021 Jul–Aug 01;41(4):370–80. doi: 10.1097/jcp.0000000000001404. PMID: 34181360. IncludeDE_KQ2 Record ID 3054 [PMC free article: PMC8244935] [PubMed: 34181360] [CrossRef]

353.

Nasser A, Liranso T, Adewole T, et al. A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children. Clin Ther. 2020 Aug;42(8):1452–66. doi: 10.1016/j.clinthera.2020.05.021. PMID: 32723670. IncludeDE_KQ2 Record ID 259 [PubMed: 32723670] [CrossRef]

354.

Nasser A, Liranso T, Adewole T, et al. A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended-Release) in Adolescents with ADHD. Psychopharmacol Bull. 2021 Mar 16;51(2):43–64. PMID: 34092822. IncludeDE_KQ2 Record ID 2978 [PMC free article: PMC8146561] [PubMed: 34092822]

355.

Nasser A, Liranso T, Adewole T, et al. Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial. Clin Ther. 2021 Apr;43(4):684–700. doi: 10.1016/j.clinthera.2021.01.027. PMID: 33750646. IncludeDE_KQ2 Record ID 3004 [PubMed: 33750646] [CrossRef]

356.

Nejati V. Program for attention rehabilitation and strengthening (PARS) improves executive functions in children with attention deficit-hyperactivity disorder (ADHD). Res Dev Disabil. 2021 Jun;113:103937. doi: 10.1016/j.ridd.2021.103937. PMID: 33756252. IncludeDE_KQ2 Record ID 4746 [PubMed: 33756252] [CrossRef]

357.

Nejati V, Fallah F, Raskin S. Inhibitory Control Training Improves Attention Deficit-Hyperactivity Disorder Symptoms and Externalizing Behavior. Clin Child Psychol Psychiatry. 2022 Dec 6;28(3):13591045221144356. doi: 10.1177/13591045221144356. PMID: 36474404. IncludeDE_KQ2 Record ID 23876 [PubMed: 36474404] [CrossRef]

358.

Neurofeedback Collaborative G. Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up. J Am Acad Child Adolesc Psychiatry. 2021 Jul;60(7):841–55. doi: 10.1016/j.jaac.2020.07.906. PMID: 32853703. IncludeDE_KQ2 Record ID 307 [PMC free article: PMC7904968] [PubMed: 32853703] [CrossRef]

359.

Newcorn JH, Harpin V, Huss M, et al. Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study. J Child Psychol Psychiatry. 2016 Jun;57(6):717–28. doi: 10.1111/jcpp.12492. PMID: 26871297. IncludeDE_KQ2 Record ID 13247 [PubMed: 26871297] [CrossRef]

360.

Newcorn JH, Kratochvil CJ, Allen AJ, et al. Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry. 2008 Jun;165(6):721–30. doi: 10.1176/appi.ajp.2007.05091676. PMID: 18281409. IncludeDE_KQ2 Record ID 17455 [PubMed: 18281409] [CrossRef]

361.

Newcorn JH, Spencer TJ, Biederman J, et al. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):240–8. doi: 10.1097/00004583-200503000-00008. PMID: 15725968. IncludeDE_KQ2 Record ID 17737 [PubMed: 15725968] [CrossRef]

362.

Newman E, Reddy LA. Diagnostic Utility of the Pediatric Attention Disorders Diagnostic Screener. J Atten Disord. 2017 Mar;21(5):372–80. doi: 10.1177/1087054714526431. PMID: 24639402. IncludeDE_KQ1 Record ID 634 [PubMed: 24639402] [CrossRef]

363.

Nolan EE, Volpe RJ, Gadow KD, et al. Developmental, Gender, and Comorbidity Differences in Clinically Referred Children with ADHD. Journal of Emotional and Behavioral Disorders. 1999 1999/01/01;7(1):11–20. doi: 10.1177/106342669900700102. IncludeDE_KQ1 Record ID 24462 [CrossRef]

364.

O’Neill J, O’Connor MJ, Kalender G, et al. Combining neuroimaging and behavior to discriminate children with attention deficit-hyperactivity disorder with and without prenatal alcohol exposure. Brain Imaging Behav. 2021 Jun 5. doi: 10.1007/s11682-021-00477-w. PMID: 34089460. IncludeDE_KQ1 Record ID 3354 [PMC free article: PMC8643366] [PubMed: 34089460] [CrossRef]

365.

Ogrim G KJ, Hestad K. The quantitative EEG theta/beta ratio in attention deficit/hyperactivity disorder and normal controls: sensitivity, specificity, and behavioral correlates. Psychiatry Res. 2012 Aug 15;198(3):482–8. doi: 10.1016/j.psychres.2011.12.041. IncludeDE_KQ1 Record ID 17010 [PubMed: 22425468] [CrossRef]

366.

Oppenheimer J, Ojo O, Antonetty A, et al. Timely Interventions for Children with ADHD through Web-Based Monitoring Algorithms. Diseases. 2019 Feb 7;7(1). doi: 10.3390/diseases7010020. PMID: 30736492. IncludeDE_KQ2_IncludeDE_KQ3 Record ID 19197 [PMC free article: PMC6473761] [PubMed: 30736492] [CrossRef]

367.

Öztekin I, Finlayson MA, Graziano PA, et al. Is there any incremental benefit to conducting neuroimaging and neurocognitive assessments in the diagnosis of ADHD in young children? A machine learning investigation. Developmental Cognitive Neuroscience. 2021 Jun 2021;49. IncludeDE_KQ1 Record ID 12088

368.

Öztoprak H, Toycan M, Alp YK, et al. Machine-based classification of ADHD and nonADHD participants using time/frequency features of event-related neuroelectric activity. Clin Neurophysiol. 2017 Dec;128(12):2400–10. doi: 10.1016/j.clinph.2017.09.105. PMID: 29096213. IncludeDE_KQ1 Record ID 2032 [PubMed: 29096213] [CrossRef]

369.

Park J, Kim C, Ahn JH, et al. Clinical Use of Continuous Performance Tests to Diagnose Children With ADHD. J Atten Disord. 2019 Apr;23(6):531–40. doi: 10.1177/1087054716658125. PMID: 27412120. IncludeDE_KQ1 Record ID 694 [PubMed: 27412120] [CrossRef]

370.

Parker A, Corkum P. ADHD Diagnosis: As Simple As Administering a Questionnaire or a Complex Diagnostic Process? Journal of Attention Disorders. 2016 Jun;20(6):478–86. doi: 10.1177/1087054713495736. PMID: 23887860. IncludeDE_KQ1 Record ID 8 [PubMed: 23887860] [CrossRef]

371.

Peijnenborgh JC, Hurks PP, Aldenkamp AP, et al. A Study on the Validity of a Computer-Based Game to Assess Cognitive Processes, Reward Mechanisms, and Time Perception in Children Aged 4-8 Years. JMIR Serious Games. 2016 Sep 22;4(2):e15. doi: 10.2196/games.5997. PMID: 27658428. IncludeDE_KQ1 Record ID 19087 [PMC free article: PMC5054232] [PubMed: 27658428] [CrossRef]

372.

Pelham WE, Jr., Fabiano GA, Waxmonsky JG, et al. Treatment sequencing for childhood ADHD: a multiple-randomization study of adaptive medication and behavioral interventions. J Clin Child Adolesc Psychol. 2016 Jul–Aug;45(4):396–415. doi: 10.1080/15374416.2015.1105138. PMID: 26882332. IncludeDE_KQ2 Record ID 33 [PMC free article: PMC4930381] [PubMed: 26882332] [CrossRef]

373.

Pelsser LM, Frankena K, Toorman J, et al. Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): A randomised controlled trial. The Lancet. 2011;377(9764):494–503. IncludeDE_KQ2 Record ID 14037

374.

Pereda E, García-Torres M, Melián-Batista B, et al. The blessing of Dimensionality: Feature Selection outperforms functional connectivity-based feature transformation to classify ADHD subjects from EEG patterns of phase synchronisation. PLoS One. 2018;13(8):e0201660. doi: 10.1371/journal.pone.0201660. PMID: 30114248. IncludeDE_KQ1 Record ID 1674 [PMC free article: PMC6095525] [PubMed: 30114248] [CrossRef]

375.

Perez-Alvarez F, Serra-Amaya C, Timoneda-Gallart CA. Cognitive versus behavioral ADHD phenotype: what is it all about? Neuropediatrics. 2009 Feb;40(1):32–8. doi: 10.1055/s-0029-1231055. PMID: 19639526. IncludeDE_KQ2 Record ID 17336 [PubMed: 19639526] [CrossRef]

376.

Perugini EM, Harvey EA, Lovejoy DW, et al. The predictive power of combined neuropsychological measures for attention-deficit/hyperactivity disorder in children. Child Neuropsychol. 2000 Jun;6(2):101–14. doi: 10.1076/chin.6.2.101.7059. PMID: 16210207. IncludeDE_KQ1 Record ID 27293 [PubMed: 16210207] [CrossRef]

377.

Pfiffner LJ HS, Owens E, et al. A two-site randomized clinical trial of integrated psychosocial treatment for ADHD-inattentive type. J Consult Clin Psychol. 2014 Dec;82(6):1115–27. doi: 10.1037/a0036887. IncludeDE_KQ2 Record ID 17038 [PMC free article: PMC4244306] [PubMed: 24865871] [CrossRef]

378.

Pineda DA, Lopera F, Puerta IC, et al. Potential cognitive endophenotypes in multigenerational families: segregating ADHD from a genetic isolate. Atten Defic Hyperact Disord. 2011 Sep;3(3):291–9. doi: 10.1007/s12402-011-0061-3. PMID: 21779842. IncludeDE_KQ1 Record ID 23386 [PMC free article: PMC4131930] [PubMed: 21779842] [CrossRef]

379.

Pongpitakdamrong A, Chirdkiatgumchai V, Ruangdaraganon N, et al. Effect of Iron Supplementation in Children with Attention-Deficit/Hyperactivity Disorder and Iron Deficiency: A Randomized Controlled Trial. J Dev Behav Pediatr. 2021 Jul 26;43(2):80–6. doi: 10.1097/dbp.0000000000000993. PMID: 34313619. IncludeDE_KQ2 Record ID 4839 [PubMed: 34313619] [CrossRef]

380.

Power TJ, Doherty BJ, Panichelli-Mindel SM, et al. The Predictive Validity of Parent and Teacher Reports of ADHD Symptoms. Journal of Psychopathology and Behavioral Assessment. 1998 1998/03/01;20(1):57–81. doi: 10.1023/A:1023035426642. IncludeDE_KQ1 Record ID 27355 [CrossRef]

381.

Power TJ MJ, Soffer SL, et al. A family-school intervention for children with ADHD: results of a randomized clinical trial. J Consult Clin Psychol. 2012 Aug;80(4):611–23. doi: 10.1037/a0028188. IncludeDE_KQ2 Record ID 17039 [PMC free article: PMC3404236] [PubMed: 22506793] [CrossRef]

382.

Prasad S, Harpin V, Poole L, et al. A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Curr Med Res Opin. 2007 Feb;23(2):379–94. doi: 10.1185/030079906x167309. PMID: 17288692. IncludeDE_KQ2 Record ID 17526 [PubMed: 17288692] [CrossRef]

383.

Preston AS, Fennell EB, Bussing R. Utility of a CPT in diagnosing ADHD among a representative sample of high-risk children: a cautionary study. Child Neuropsychol. 2005 Oct;11(5):459–69. doi: 10.1080/09297040591001067. PMID: 16306020. IncludeDE_KQ1 Record ID 27295 [PubMed: 16306020] [CrossRef]

384.

Purper-Ouakil D, Blasco-Fontecilla H, Ros T, et al. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial. J Child Psychol Psychiatry. 2021 Jun 24. doi: 10.1111/jcpp.13462. PMID: 34165190. IncludeDE_KQ2 Record ID 3169 [PubMed: 34165190] [CrossRef]

385.

Qian X, Loo BRY, Castellanos FX, et al. Brain-computer-interface-based intervention re-normalizes brain functional network topology in children with attention deficit/hyperactivity disorder. Transl Psychiatry. 2018 Aug 10;8(1):149. doi: 10.1038/s41398-018-0213-8. PMID: 30097579. IncludeDE_KQ2 Record ID 416 [PMC free article: PMC6086861] [PubMed: 30097579] [CrossRef]

386.

Qian Y, Fan Z, Gao B, et al. Efficacy and acceptability of a second dose of ecological executive skills training for children with ADHD: a randomized controlled study and follow-up. Eur Child Adolesc Psychiatry. 2021 Jun;30(6):921–35. doi: 10.1007/s00787-020-01571-y. PMID: 32596788. IncludeDE_KQ2 Record ID 369 [PubMed: 32596788] [CrossRef]

387.

Qin L, Liu H, Zhang H, et al. Evaluation of the diagnostic implications of Das-Naglieri cognitive assessment system in children with attention deficit hyperactivity disorder. BMC Psychiatry. 2018 Dec 12;18(1):386. doi: 10.1186/s12888-018-1970-x. PMID: 30541503. IncludeDE_KQ1 Record ID 1057 [PMC free article: PMC6292108] [PubMed: 30541503] [CrossRef]

388.

Quintana H, Snyder SM, Purnell W, et al. Comparison of a standard psychiatric evaluation to rating scales and EEG in the differential diagnosis of attention-deficit/hyperactivity disorder. Psychiatry Res. 2007 Aug 30;152(2–3):211–22. doi: 10.1016/j.psychres.2006.04.015. PMID: 17451810. IncludeDE_KQ1 Record ID 23411 [PubMed: 17451810] [CrossRef]

389.

Rafeiy-Torghabeh M, Ashraf-Ganjouei A, Moradi K, et al. Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial. Eur Child Adolesc Psychiatry. 2021 May;30(5):799–807. doi: 10.1007/s00787-020-01562-z. PMID: 32449130. IncludeDE_KQ2 Record ID 318 [PubMed: 32449130] [CrossRef]

390.

Raghuveer R, Ruchi. Comparative efficacy of structured games and behavioural parent training on working memory in children with attention deficit hyperactivity disorder: A pilot study. Journal of Clinical and Diagnostic Research. 2020;14(7):YC01–YC4. doi: 10.7860/JCDR/2020/43576.13807. IncludeDE_KQ2 Record ID 9117 [CrossRef]

391.

Rahmani M, Mahvelati A, Farajinia AH, et al. Comparison of Vitamin D, Neurofeedback, and Neurofeedback Combined with Vitamin D Supplementation in Children with Attention-Deficit/Hyperactivity Disorder. Arch Iran Med. 2022 May 1;25(5):285–393. doi: 10.34172/aim.2022.47. PMID: 35943003. IncludeDE_KQ2 Record ID 26483 [PubMed: 35943003] [CrossRef]

392.

Raiker JS, Freeman AJ, Perez-Algorta G, et al. Accuracy of Achenbach Scales in the Screening of Attention-Deficit/Hyperactivity Disorder in a Community Mental Health Clinic. J Am Acad Child Adolesc Psychiatry. 2017 May;56(5):401–9. doi: 10.1016/j.jaac.2017.02.007. PMID: 28433089. IncludeDE_KQ1 Record ID 790 [PMC free article: PMC5410964] [PubMed: 28433089] [CrossRef]

393.

Rajabi S, Pakize A, Moradi N. Effect of combined neurofeedback and game-based cognitive training on the treatment of ADHD: A randomized controlled study. Applied Neuropsychology: Child. 2020 2020/07/02;9(3):193–205. doi: 10.1080/21622965.2018.1556101. PMID: 30734583. IncludeDE_KQ2 Record ID 43 [PubMed: 30734583] [CrossRef]

394.

Reddy LA, Alperin A, Lekwa A. Construct Validity and Diagnostic Utility of the Woodcock Johnson Tests of Cognitive Abilities and Clinical Clusters for Children with Attention Deficit/Hyperactivity Disorder: A Preliminary Investigation. European Journal of Psychology and Educational Research. 2021 01/01/;4(1):36–49. PMID: EJ1333596. IncludeDE_KQ1 Record ID 26493

395.

Rezaeezadeh M, Shamekhi S, Shamsi M. Attention Deficit Hyperactivity Disorder Diagnosis using non-linear univariate and multivariate EEG measurements: a preliminary study. Phys Eng Sci Med. 2020 Jun;43(2):577–92. doi: 10.1007/s13246-020-00858-3. PMID: 32524443. IncludeDE_KQ1 Record ID 1136 [PubMed: 32524443] [CrossRef]

396.

Riaz A, Asad M, Alonso E, et al. DeepFMRI: End-to-end deep learning for functional connectivity and classification of ADHD using fMRI. J Neurosci Methods. 2020 Apr 1;335:108506. doi: 10.1016/j.jneumeth.2019.108506. PMID: 32001294. IncludeDE_KQ1 (ADHD-200) Record ID 1606 [PubMed: 32001294] [CrossRef]

397.

Rielly NE, Cunningham CE, Richards JE, et al. Detecting Attention Deficit Hyperactivity Disorder in a communications clinic: diagnostic utility of the Gordon Diagnostic System. J Clin Exp Neuropsychol. 1999 Oct;21(5):685–700. doi: 10.1076/jcen.21.5.685.866. PMID: 10572287. IncludeDE_KQ1 Record ID 27296 [PubMed: 10572287] [CrossRef]

398.

Riggs PD, Winhusen T, Davies RD, et al. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):903–14. doi: 10.1016/j.jaac.2011.06.010. PMID: 21871372. IncludeDE_KQ2 Record ID 17098 [PMC free article: PMC3164797] [PubMed: 21871372] [CrossRef]

399.

Rishel CW, Greeno C, Marcus SC, et al. Use of the Child Behavior Checklist as a Diagnostic Screening Tool in Community Mental Health. Research on Social Work Practice. 2005 2005/05/01;15(3):195–203. doi: 10.1177/1049731504270382. IncludeDE_KQ1 Record ID 24682 [CrossRef]

400.

Robles R, de la Peña FR, Medina-Mora ME, et al. ICD-11 Guidelines for Mental and Behavioral Disorders of Children and Adolescents: Reliability and Clinical Utility. Psychiatr Serv. 2021 Aug 26;73(4):appips202000830. doi: 10.1176/appi.ps.202000830. PMID: 34433288. IncludeDE_KQ1 Record ID 3244 [PubMed: 34433288] [CrossRef]

401.

Rodríguez C, Areces D, García T, et al. Comparison between two continuous performance tests for identifying ADHD: Traditional vs. Virtual reality. International Journal of Clinical and Health Psychology. 2018 Sep 2018 - Dec 2018;18(3):254–63. IncludeDE_KQ1 Record ID 12204 [PMC free article: PMC6225036] [PubMed: 30487931]

402.

Roessner V, Walitza S, Riederer F, et al. Tetrahydroisoquinoline derivatives: A new perspective on monoaminergic dysfunction in children with ADHD? Behavioral and Brain Functions. 2007;3. doi: 10.1186/1744-9081-3-64. IncludeDE_KQ1 Record ID 18623 [CrossRef]

403.

Rogers EA, Graves SJ, Freeman AJ, et al. Improving accuracy of ADHD subtype diagnoses with the ADHD symptom rating scale. Child Neuropsychol. 2022 Oct;28(7):962–78. doi: 10.1080/09297049.2022.2044768. PMID: 35287549. IncludeDE_KQ1 Record ID 26515 [PubMed: 35287549] [CrossRef]

404.

Rothe J, Kattlun FA, Kaufmann J, et al. Effects of methylphenidate and physiotherapeutic treatment on graphomotor movements in children with ADHD. Eur Child Adolesc Psychiatry. 2023 Jan 23. doi: 10.1007/s00787-023-02144-5. PMID: 36688969. IncludeDE_KQ2 Record ID 26523 [PMC free article: PMC10806214] [PubMed: 36688969] [CrossRef]

405.

Rubio Morell B, Hernández Expósito S. Differential long-term medication impact on executive function and delay aversion in ADHD. Appl Neuropsychol Child. 2019 Apr–Jun;8(2):140–57. doi: 10.1080/21622965.2017.1407653. PMID: 29244542. IncludeDE_KQ2 Record ID 4907 [PubMed: 29244542] [CrossRef]

406.

Rucklidge JJ, Eggleston MJF, Johnstone JM, et al. Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial. J Child Psychol Psychiatry. 2018 Mar;59(3):232–46. doi: 10.1111/jcpp.12817. PMID: 28967099. IncludeDE_KQ2 Record ID 4909 [PMC free article: PMC7779340] [PubMed: 28967099] [CrossRef]

407.

Rucklidge JJ, Tannock R. Validity of the Brown ADD scales: an investigation in a predominantly inattentive ADHD adolescent sample with and without reading disabilities. J Atten Disord. 2002 Jan;5(3):155–64. doi: 10.1177/108705470200500303. PMID: 11911008. IncludeDE_KQ1 Record ID 27357 [PubMed: 11911008] [CrossRef]

408.

Saito T, Yamashita Y, Tomoda A, et al. Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder. BMC Psychiatry. 2020 Nov 10;20(1):530. doi: 10.1186/s12888-020-02932-2. PMID: 33167920. IncludeDE_KQ2 Record ID 371 [PMC free article: PMC7653993] [PubMed: 33167920] [CrossRef]

409.

Salardini E, Zeinoddini A, Kohi A, et al. Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial. J Child Adolesc Psychopharmacol. 2016 Aug;26(6):513–9. doi: 10.1089/cap.2016.0024. PMID: 27286139. IncludeDE_KQ2 Record ID 13376 [PubMed: 27286139] [CrossRef]

410.

Salehi B, Imani R, Mohammadi MR, et al. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):76–80. doi: 10.1016/j.pnpbp.2009.09.026. PMID: 19815048. IncludeDE_KQ2 Record ID 17221 [PubMed: 19815048] [CrossRef]

411.

Salehi B, Mohammadbeigi A, Sheykholeslam H, et al. Omega-3 and Zinc supplementation as complementary therapies in children with attention-deficit/hyperactivity disorder. J Res Pharm Pract. 2016 Jan–Mar;5(1):22–6. doi: 10.4103/2279-042x.176561. PMID: 26985432. IncludeDE_KQ2 Record ID 13378 [PMC free article: PMC4776543] [PubMed: 26985432] [CrossRef]

412.

Sallee FR, McGough J, Wigal T, et al. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009 Feb;48(2):155–65. doi: 10.1097/CHI.0b013e318191769e. PMID: 19106767. IncludeDE_KQ2 Record ID 17319 [PubMed: 19106767] [CrossRef]

413.

Sangal RB, Owens J, Allen AJ, et al. Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep. 2006 Dec;29(12):1573–85. doi: 10.1093/sleep/29.12.1573. PMID: 17252888. IncludeDE_KQ2 Record ID 17628 [PubMed: 17252888] [CrossRef]

414.

Sangal RB BJ, Lankford DA, Grinnell TA, Huang H. Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder. Pediatrics. 2014 Oct;134(4):e1095–103. doi: 10.1542/peds.2013-4221. PMID: 25266438. IncludeDE_KQ2 Record ID 19250 [PubMed: 25266438] [CrossRef]

415.

Satin MS, Winsberg BG, Monetti CH, et al. A general population screen for attention deficit disorder with hyperactivity. J Am Acad Child Psychiatry. 1985 Nov;24(6):756–64. doi: 10.1016/s0002-7138(10)60120-3. PMID: 4067144. IncludeDE_KQ1 Record ID 27358 [PubMed: 4067144] [CrossRef]

416.

Schatz AM, Ballantyne AO, Trauner DA. Sensitivity and specificity of a computerized test of attention in the diagnosis of Attention-Deficit/Hyperactivity Disorder. Assessment. 2001 Dec;8(4):357–65. doi: 10.1177/107319110100800401. PMID: 11785580. IncludeDE_KQ1 Record ID 23497 [PubMed: 11785580] [CrossRef]

417.

Scheeringa MS. The Diagnostic Infant Preschool Assessment-Likert Version: Preparation, Concurrent Construct Validation, and Test-Retest Reliability. J Child Adolesc Psychopharmacol. 2020 Jun;30(5):326–34. doi: 10.1089/cap.2019.0168. PMID: 32159386. IncludeDE_KQ1 Record ID 563 [PubMed: 32159386] [CrossRef]

418.

Schertz M, Karni-Visel Y, Genizi J, et al. Transcranial Direct Current Stimulation (tDCS) in children with ADHD: A randomized, sham-controlled pilot study. J Psychiatr Res. 2022 Nov;155:302–12. doi: 10.1016/j.jpsychires.2022.08.022. PMID: 36174365. IncludeDE_KQ2 Record ID 26551 [PubMed: 36174365] [CrossRef]

419.

Schirmer MD, Venkataraman A, Rekik I, et al. Neuropsychiatric disease classification using functional connectomics - results of the connectomics in neuroimaging transfer learning challenge. Med Image Anal. 2021 May;70:101972. doi: 10.1016/j.media.2021.101972. PMID: 33677261. IncludeDE_KQ1 Record ID 3047 [PMC free article: PMC9115580] [PubMed: 33677261] [CrossRef]

420.

Schneider H, Ryan M, Mahone EM. Parent versus teacher ratings on the BRIEF-preschool version in children with and without ADHD. Child Neuropsychol. 2020 Jan;26(1):113–28. doi: 10.1080/09297049.2019.1617262. PMID: 31094642. IncludeDE_KQ1 Record ID 1866 [PMC free article: PMC6858515] [PubMed: 31094642] [CrossRef]

421.

Schorr-Sapir I, Gershy N, Apter A, et al. Parent training in non-violent resistance for children with attention deficit hyperactivity disorder: a controlled outcome study. Eur Child Adolesc Psychiatry. 2021 Feb 2. doi: 10.1007/s00787-021-01723-8. PMID: 33528659. IncludeDE_KQ2 Record ID 3308 [PubMed: 33528659] [CrossRef]

422.

Schramm SA, Hennig T, Linderkamp F. Training Problem Solving and Organizational Skills in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial. Journal of Cognitive Education and Psychology. 2016 01/01/;15(3):391–411. PMID: EJ1226769. IncludeDE_KQ2 Record ID 10874

423.

Schuck SEB, Emmerson NA, Abdullah MM, et al. A Randomized Controlled Trial of Traditional Psychosocial and Canine-Assisted Interventions for Children with ADHD. Human-Animal Interaction Bulletin. 2018;6(1):64–80. IncludeDE_KQ2 Record ID 19228

424.

Sciberras E, Mulraney M, Mensah F, et al. Sustained impact of a sleep intervention and moderators of treatment outcome for children with ADHD: a randomised controlled trial. Psychol Med. 2020 Jan;50(2):210–9. doi: 10.1017/s0033291718004063. PMID: 30654852. IncludeDE_KQ2 Record ID 419 [PubMed: 30654852] [CrossRef]

425.

Serrallach B, Groß C, Bernhofs V, et al. Neural biomarkers for dyslexia, ADHD, and ADD in the auditory cortex of children. Frontiers in Neuroscience. 2016;10(JUL). doi: 10.3389/fnins.2016.00324. IncludeDE_KQ1 Record ID 9446 [CrossRef]

426.

Shang CY, Shih HH, Pan YL, et al. Comparative Efficacy of Methylphenidate and Atomoxetine on Social Adjustment in Youths with Attention-Deficit/Hyperactivity Disorder. J Child Adolesc Psychopharmacol. 2020 Apr;30(3):148–58. doi: 10.1089/cap.2019.0139. PMID: 31794244. IncludeDE_KQ2 Record ID 345 [PubMed: 31794244] [CrossRef]

427.

Shaywitz S, Shaywitz B, Wietecha L, et al. Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial. J Child Adolesc Psychopharmacol. 2017 Feb;27(1):19–28. doi: 10.1089/cap.2015.0189. PMID: 27410907. IncludeDE_KQ2 Record ID 296 [PMC free article: PMC5327054] [PubMed: 27410907] [CrossRef]

428.

Shemmassian SK, Lee SS. Predictive Utility of Four Methods of Incorporating Parent and Teacher Symptom Ratings of ADHD for Longitudinal Outcomes. J Clin Child Adolesc Psychol. 2016;45(2):176–87. doi: 10.1080/15374416.2014.971457. PMID: 25643854. IncludeDE_KQ1 Record ID 13408 [PubMed: 25643854] [CrossRef]

429.

Shemmassian SK, Lee SS. Comparative Validity of DSM-IV and Alternative Empirically Derived Approaches for the Assessment of ADHD. J Atten Disord. 2017 Mar;21(5):405–15. doi: 10.1177/1087054714522511. PMID: 24532800. IncludeDE_KQ1 Record ID 769 [PubMed: 24532800] [CrossRef]

430.

Shen L, Wang C, Tian Y, et al. Effects of Parent-Teacher Training on Academic Performance and Parental Anxiety in School-Aged Children With Attention-Deficit/Hyperactivity Disorder: A Cluster Randomized Controlled Trial in Shanghai, China. Front Psychol. 2021;12:733450. doi: 10.3389/fpsyg.2021.733450. PMID: 34955960. IncludeDE_KQ2 Record ID 19124 [PMC free article: PMC8695601] [PubMed: 34955960] [CrossRef]

431.

Shuai L, Wang Y, Li W, et al. Executive Function Training for Preschool Children With ADHD: A Randomized Controlled Trial. J Atten Disord. 2020 Sep 23:1087054720956723. doi: 10.1177/1087054720956723. PMID: 32964771. IncludeDE_KQ2 Record ID 3265 [PubMed: 32964771] [CrossRef]

432.

Sibley MH, Coxe SJ, Campez M, et al. High versus Low Intensity Summer Treatment for ADHD Delivered at Secondary School Transitions. J Clin Child Adolesc Psychol. 2018 Mar–Apr;47(2):248–65. doi: 10.1080/15374416.2018.1426005. PMID: 29498550. IncludeDE_KQ2 Record ID 4979 [PubMed: 29498550] [CrossRef]

433.

Sibley MH, Graziano PA, Coxe S, et al. Effectiveness of Motivational Interviewing-Enhanced Behavior Therapy for Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized Community-Based Trial. J Am Acad Child Adolesc Psychiatry. 2021 Jun;60(6):745–56. doi: 10.1016/j.jaac.2020.07.907. PMID: 32861773. IncludeDE_KQ2 Record ID 313 [PMC free article: PMC7907265] [PubMed: 32861773] [CrossRef]

434.

Sibley MH, Graziano PA, Kuriyan AB, et al. Parent–teen behavior therapy + motivational interviewing for adolescents with ADHD. Journal of Consulting and Clinical Psychology. 2016 Aug 2016;84(8):699–712. doi: 10.1037/ccp0000106. PMID: 27077693. IncludeDE_KQ2 Record ID 12327 [PMC free article: PMC4949080] [PubMed: 27077693] [CrossRef]

435.

Sibley MH, Rodriguez L, Coxe S, et al. Parent-Teen Group versus Dyadic Treatment for Adolescent ADHD: What Works for Whom? J Clin Child Adolesc Psychol. 2020 Jul–Aug;49(4):476–92. doi: 10.1080/15374416.2019.1585257. PMID: 30990088. IncludeDE_KQ2 Record ID 308 [PubMed: 30990088] [CrossRef]

436.

Siebelink NM, Bögels SM, Speckens AEM, et al. A randomised controlled trial (MindChamp) of a mindfulness-based intervention for children with ADHD and their parents. J Child Psychol Psychiatry. 2021 May 24. doi: 10.1111/jcpp.13430. PMID: 34030214. IncludeDE_KQ2 Record ID 3333 [PMC free article: PMC9292876] [PubMed: 34030214] [CrossRef]

437.

Silverstein M, Hironaka LK, Feinberg E, et al. Using Clinical Data to Predict Accurate ADHD Diagnoses Among Urban Children. Clin Pediatr (Phila). 2016 Apr;55(4):326–32. doi: 10.1177/0009922815591882. PMID: 26130393. IncludeDE_KQ1 Record ID 13421 [PubMed: 26130393] [CrossRef]

438.

Simões EN, Carvalho ALN, Schmidt SL. The Role of Visual and Auditory Stimuli in Continuous Performance Tests: Differential Effects on Children With ADHD. J Atten Disord. 2021 Jan;25(1):53–62. doi: 10.1177/1087054718769149. PMID: 29671360. IncludeDE_KQ1 Record ID 1614 [PubMed: 29671360] [CrossRef]

439.

Simonoff E, Taylor E, Baird G, et al. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. J Child Psychol Psychiatry. 2013 May;54(5):527–35. doi: 10.1111/j.1469-7610.2012.02569.x. PMID: 22676856. IncludeDE_KQ2 Record ID 14570 [PubMed: 22676856] [CrossRef]

440.

Sinai ISoMaM, Health NIoM. Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach. 2012. IncludeDE_KQ2 Record ID 13888

441.

Singer HS, Brown J, Quaskey S, et al. The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics. 1995 Jan;95(1):74–81. PMID: 7770313. IncludeDE_KQ2 Record ID 18112 [PubMed: 7770313]

442.

Skogli EW, Teicher MH, Andersen PN, et al. ADHD in girls and boys--gender differences in co-existing symptoms and executive function measures. BMC Psychiatry. 2013 Nov 9;13:298. doi: 10.1186/1471-244X-13-298. PMID: 24206839. IncludeDE_KQ1 Record ID 24467 [PMC free article: PMC3827008] [PubMed: 24206839] [CrossRef]

443.

Slaby I, Hain HS, Abrams D, et al. An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities. J Neurodev Disord. 2022 Jun 11;14(1):37. doi: 10.1186/s11689-022-09447-9. PMID: 35690720. IncludeDE_KQ1 Record ID 19352 [PMC free article: PMC9188139] [PubMed: 35690720] [CrossRef]

444.

Slobodin O, Yahav I, Berger I. A Machine-Based Prediction Model of ADHD Using CPT Data. Front Hum Neurosci. 2020;14:560021. doi: 10.3389/fnhum.2020.560021. PMID: 33093829. IncludeDE_KQ1 Record ID 3289 [PMC free article: PMC7528635] [PubMed: 33093829] [CrossRef]

445.

Smit S, Mikami AY, Normand S. Effects of the Parental Friendship Coaching Intervention on Parental Emotion Socialization of Children with ADHD. Res Child Adolesc Psychopathol. 2021 May 26. doi: 10.1007/s10802-021-00818-9. PMID: 34037888. IncludeDE_KQ2 Record ID 5004 [PubMed: 34037888] [CrossRef]

446.

Smith BH, Pelham WE, Gnagy E, et al. The reliability, validity, and unique contributions of self-report by adolescents receiving treatment for attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2000 Jun;68(3):489–99. doi: 10.1037/0022-006x.68.3.489. PMID: 10883565. IncludeDE_KQ3 Record ID 18003 [PubMed: 10883565] [CrossRef]

447.

Smith JL, Johnstone SJ, Barry RJ. Aiding diagnosis of attention-deficit/hyperactivity disorder and its subtypes: discriminant function analysis of event-related potential data. J Child Psychol Psychiatry. 2003 Oct;44(7):1067–75. doi: 10.1111/1469-7610.00191. PMID: 14531589. IncludeDE_KQ1 Record ID 23576 [PubMed: 14531589] [CrossRef]

448.

Smith SR, Wingenfeld SA, Hilsenroth MJ, et al. The Use of the Devereux Scales of Mental Disorders in the Assessment of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder. Journal of Psychopathology and Behavioral Assessment. 2000 2000/09/01;22(3):237–55. doi: 10.1023/A:1007510216543. IncludeDE_KQ1 Record ID 27360 [CrossRef]

449.

Snyder SM, Quintana H, Sexson SB, et al. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Psychiatry Res. 2008 Jun 30;159(3):346–58. doi: 10.1016/j.psychres.2007.05.006. PMID: 18423617. IncludeDE_KQ1 Record ID 23581 [PubMed: 18423617] [CrossRef]

450.

Snyder SM, Rugino TA, Hornig M, et al. Integration of an EEG biomarker with a clinician’s ADHD evaluation. Brain and Behavior. 2015 Apr;5(4):e00330. doi: 10.1002/brb3.330. PMID: 25798338. IncludeDE_KQ1 Record ID 17 [PMC free article: PMC4356845] [PubMed: 25798338] [CrossRef]

451.

Soliva JC FJ, Bielsa A, et al. Quantitative MR analysis of caudate abnormalities in pediatric ADHD: proposal for a diagnostic test. Psychiatry Res. 2010 Jun 30;182(3):238–43. doi: 10.1016/j.pscychresns.2010.01.013. IncludeDE_KQ1 Record ID 17012 [PubMed: 20488672] [CrossRef]

452.

Sonuga-Barke EJ DD, Thompson M, et al. Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample. J Am Acad Child Adolesc Psychiatry. 2001;40(4):402–8. IncludeDE_KQ2 Record ID 18279 [PubMed: 11314565]

453.

Sonuga-Barke EJ TM, Daley D, et al. Parent training for Attention Deficit/Hyperactivity Disorder: is it as effective when delivered as routine rather than as specialist care? Br J Clin Psychol. 2004;43(Pt 4):4–57. IncludeDE_KQ2 Record ID 18280

454.

Sonuga-Barke EJS, Barton J, Daley D, et al. A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the New Forest Parenting Programme versus Incredible Years. Eur Child Adolesc Psychiatry. 2018 Jun;27(6):797–809. doi: 10.1007/s00787-017-1054-3. PMID: 29086103. IncludeDE_KQ2 Record ID 497 [PMC free article: PMC5973956] [PubMed: 29086103] [CrossRef]

455.

Spencer AE, Plasencia N, Sun Y, et al. Screening for Attention-Deficit/Hyperactivity Disorder and Comorbidities in a Diverse, Urban Primary Care Setting. Clin Pediatr (Phila). 2018 Oct;57(12):1442–52. doi: 10.1177/0009922818787329. PMID: 30003797. IncludeDE_KQ1 Record ID 666 [PubMed: 30003797] [CrossRef]

456.

Spencer T, Heiligenstein JH, Biederman J, et al. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002a Dec;63(12):1140–7. doi: 10.4088/jcp.v63n1209. PMID: 12523874. IncludeDE_KQ2_Study 1 to ID 28632 Record ID 24394 [PubMed: 12523874] [CrossRef]

457.

Spencer T, Heiligenstein JH, Biederman J, et al. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2002b Dec;63(12):1140–7. doi: 10.4088/jcp.v63n1209. PMID: 12523874. IncludeDE_KQ2_Study 2 to ID 24394 Record ID 28632 [PubMed: 12523874] [CrossRef]

458.

Spencer TJ, Sallee FR, Gilbert DL, et al. Atomoxetine Treatment of ADHD in Children with Comorbid Tourette Syndrome. Journal of Attention Disorders. 2008 01/01/;11(4):470–81. doi: 10.1177/1087054707306109. PMID: 17934184. IncludeDE_KQ2 Record ID 18353 [PubMed: 17934184] [CrossRef]

459.

Spencer TJ, Wilens TE, Biederman J, et al. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther. 2006 Feb;28(2):266–79. doi: 10.1016/j.clinthera.2006.02.011. PMID: 16678648. IncludeDE_KQ2 Record ID 15089 [PubMed: 16678648] [CrossRef]

460.

Sprafkin J, Gadow KD. Choosing an attention-deficit/hyperactivity disorder rating scale: is item randomization necessary? J Child Adolesc Psychopharmacol. 2007 Feb;17(1):75–84. doi: 10.1089/cap.2006.0035. PMID: 17343555. IncludeDE_KQ1 Record ID 23598 [PubMed: 17343555] [CrossRef]

461.

Sprafkin J, Volpe RJ, Gadow KD, et al. A DSM-IV-referenced screening instrument for preschool children: the Early Childhood Inventory-4. J Am Acad Child Adolesc Psychiatry. 2002 May;41(5):604–12. doi: 10.1097/00004583-200205000-00018. PMID: 12014793. IncludeDE_KQ1 Record ID 27362 [PubMed: 12014793] [CrossRef]

462.

Sprich SE, Safren SA, Finkelstein D, et al. A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents. J Child Psychol Psychiatry. 2016 Nov;57(11):1218–26. doi: 10.1111/jcpp.12549. PMID: 26990084. IncludeDE_KQ2 Record ID 261 [PMC free article: PMC5026858] [PubMed: 26990084] [CrossRef]

463.

Steele M WM, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol. 2006 Winter;13(1):e50–62. PMID: 16456216. IncludeDE_KQ2 Record ID 19235 [PubMed: 16456216]

464.

Steiner NJ FE, Rene KM, et al. In-school neurofeedback training for ADHD: sustained improvements from a randomized control trial. Pediatrics. 2014 Mar;133(3):483–92. doi: 10.1542/peds.2013-2059. IncludeDE_KQ2 Record ID 17053 [PubMed: 24534402] [CrossRef]

465.

Stepanova E, Findling RL, Kaplin D, et al. An Examination of Blood Cell Membrane Potential as a Diagnostic Test of Attention Deficit Disorder in Children. J Atten Disord. 2021 Jan;25(1):73–80. doi: 10.1177/1087054718772169. PMID: 29707999. IncludeDE_KQ1 Record ID 907 [PubMed: 29707999] [CrossRef]

466.

Stevanovic D, Nasic S, Doric A, et al. The Structure and Diagnostic Accuracy of the QbTest in Pediatric ADHD: A Retrospective Clinical Study. J Atten Disord. 2023 May 18:10870547231174035. doi: 10.1177/10870547231174035. PMID: 37199293. IncludeDE_KQ1 Record ID 27753 [PubMed: 37199293] [CrossRef]

467.

Storebo OJ GC, Winkel P, et al. Social-skills and parental training plus standard treatment versus standard treatment for children with ADHD--the randomised SOSTRA trial. PLoS One. 2012;7(6):e37280. doi: 10.1371/journal.pone.0037280. IncludeDE_KQ2 Record ID 17044 [PMC free article: PMC3380035] [PubMed: 22745657] [CrossRef]

468.

Straub L, Bateman BT, Hernandez-Diaz S, et al. Validity of claims-based algorithms to identify neurodevelopmental disorders in children. Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1635–42. doi: 10.1002/pds.5369. PMID: 34623720. IncludeDE_KQ1 Record ID 19146 [PMC free article: PMC8578450] [PubMed: 34623720] [CrossRef]

469.

Strehl U, Aggensteiner P, Wachtlin D, et al. Neurofeedback of Slow Cortical Potentials in Children with Attention-Deficit/Hyperactivity Disorder: A Multicenter Randomized Trial Controlling for Unspecific Effects. Front Hum Neurosci. 2017;11:135. doi: 10.3389/fnhum.2017.00135. PMID: 28408873. IncludeDE_KQ2 Record ID 3452 [PMC free article: PMC5374218] [PubMed: 28408873] [CrossRef]

470.

Su Y, Yang L, Stein MA, et al. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up. J Child Adolesc Psychopharmacol. 2016 May;26(4):362–71. doi: 10.1089/cap.2015.0031. PMID: 26779845. IncludeDE_KQ2 Record ID 13455 [PubMed: 26779845] [CrossRef]

471.

Sugaya LS, Salum GA, de Sousa Gurgel W, et al. Efficacy and safety of methylphenidate and behavioural parent training for children aged 3-5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial. Lancet Child Adolesc Health. 2022 Dec;6(12):845–56. doi: 10.1016/s2352-4642(22)00279-6. PMID: 36306807. IncludeDE_KQ2 Record ID 26633 [PMC free article: PMC9731509] [PubMed: 36306807] [CrossRef]

472.

Sullivan JR, Riccio CA. Diagnostic group differences in parent and teacher ratings on the BRIEF and Conners’ Scales. J Atten Disord. 2007 Nov;11(3):398–406. doi: 10.1177/1087054707299399. PMID: 17932389. IncludeDE_KQ1 Record ID 23625 [PubMed: 17932389] [CrossRef]

473.

Sun H, Chen Y, Huang Q, et al. Psychoradiologic Utility of MR Imaging for Diagnosis of Attention Deficit Hyperactivity Disorder: A Radiomics Analysis. Radiology. 2018 May;287(2):620–30. doi: 10.1148/radiol.2017170226. PMID: 29165048. IncludeDE_KQ1 Record ID 802 [PubMed: 29165048] [CrossRef]

474.

Supernus Pharmaceuticals I. Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1). 2016. IncludeDE_KQ2 Record ID 13857

475.

Svanborg P, Thernlund G, Gustafsson PA, et al. Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents. Eur Child Adolesc Psychiatry. 2009 Apr;18(4):240–9. doi: 10.1007/s00787-008-0725-5. PMID: 19156355. IncludeDE_KQ2 Record ID 17314 [PubMed: 19156355] [CrossRef]

476.

Swanson JM, Greenhill LL, Lopez FA, et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry. 2006 Jan;67(1):137–47. doi: 10.4088/jcp.v67n0120. PMID: 16426100. IncludeDE_KQ2 Record ID 14341 [PubMed: 16426100] [CrossRef]

477.

Takahashi M, Takita Y, Yamazaki K, et al. A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Aug;19(4):341–50. doi: 10.1089/cap.2008.0154. PMID: 19702486. IncludeDE_KQ2 Record ID 17312 [PubMed: 19702486] [CrossRef]

478.

Tallberg P, Råstam M, Wenhov L, et al. Incremental clinical utility of continuous performance tests in childhood ADHD - an evidence-based assessment approach. Scand J Psychol. 2019 Feb;60(1):26–35. doi: 10.1111/sjop.12499. PMID: 30452083. IncludeDE_KQ1 Record ID 798 [PMC free article: PMC7379623] [PubMed: 30452083] [CrossRef]

479.

Tamm L, Denton CA, Epstein JN, et al. Comparing treatments for children with ADHD and word reading difficulties: A randomized clinical trial. J Consult Clin Psychol. 2017 May;85(5):434–46. doi: 10.1037/ccp0000170. PMID: 28333510. IncludeDE_KQ2 Record ID 5052 [PMC free article: PMC5398920] [PubMed: 28333510] [CrossRef]

480.

Tamm L, Epstein JN, Peugh JL, et al. Preliminary data suggesting the efficacy of attention training for school-aged children with ADHD. Dev Cogn Neurosci. 2013 Apr;4:16–28. doi: 10.1016/j.dcn.2012.11.004. PMID: 23219490. IncludeDE_KQ2 Record ID 27404 [PMC free article: PMC3617931] [PubMed: 23219490] [CrossRef]

481.

Tan ML, Foong SC, Foong WC, et al. Tocotrienol-rich fractions (TRF) supplementation in school-going children with Attention Deficit/Hyperactive Disorder (ADHD): a randomized controlled trial. BMC Nutrition. 2016 2016/03/21;2(1):14. doi: 10.1186/s40795-016-0055-9. IncludeDE_KQ2 Record ID 27194 [CrossRef]

482.

Tang S, Liu X, Nie L, et al. Three-dimensional pseudocontinuous arterial spin labeling perfusion imaging shows cerebral blood flow perfusion decline in attention-deficit/hyperactivity disorder children. Frontiers in Psychiatry. 2023;14. doi: 10.3389/fpsyt.2023.1064647. IncludeDE_KQ1 Record ID 25491 [CrossRef]

483.

Tang Y, Sun J, Wang C, et al. ADHD classification using auto-encoding neural network and binary hypothesis testing. Artificial Intelligence in Medicine. 2022;123. doi: 10.1016/j.artmed.2021.102209. IncludeDE_KQ1 Record ID 9744 [CrossRef]

484.

Ter-Minassian L, Viani N, Wickersham A, et al. Assessing machine learning for fair prediction of ADHD in school pupils using a retrospective cohort study of linked education and healthcare data. BMJ Open. 2022 Dec 5;12(12):e058058. doi: 10.1136/bmjopen-2021-058058. PMID: 36576182. IncludeDE_KQ1 Record ID 26667 [PMC free article: PMC9723859] [PubMed: 36576182] [CrossRef]

485.

Tian X, Liu X, Wang Y, et al. Urinary Metabolomic Study in a Healthy Children Population and Metabolic Biomarker Discovery of Attention-Deficit/Hyperactivity Disorder (ADHD). Frontiers in Psychiatry. 2022;13. doi: 10.3389/fpsyt.2022.819498. IncludeDE_KQ1 Record ID 25504 [CrossRef]

486.

Tillman R, Geller B. A brief screening tool for a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2005 Jun;162(6):1214–6. doi: 10.1176/appi.ajp.162.6.1214. PMID: 15930075. IncludeDE_KQ1 Record ID 23663 [PubMed: 15930075] [CrossRef]

487.

Tiwawatpakorn N, Worachotekamjorn J, Tassanakijpanich N. Effectiveness of Parenting Training on Emotional and Behavioral Problems in First through Fourth Grade Thai Children with ADHD: A Randomized Controlled Study. Psychol Rep. 2021 Jun 22:332941211026846. doi: 10.1177/00332941211026846. PMID: 34154470. IncludeDE_KQ2 Record ID 3625 [PubMed: 34154470] [CrossRef]

488.

Trebatická J, Kopasová S, Hradecná Z, et al. Treatment of ADHD with French maritime pine bark extract, Pycnogenol. Eur Child Adolesc Psychiatry. 2006 Sep;15(6):329–35. doi: 10.1007/s00787-006-0538-3. PMID: 16699814. IncludeDE_KQ2 Record ID 17618 [PubMed: 16699814] [CrossRef]

489.

Tripp G, Schaughency EA, Clarke B. Parent and teacher rating scales in the evaluation of attention-deficit hyperactivity disorder: contribution to diagnosis and differential diagnosis in clinically referred children. J Dev Behav Pediatr. 2006 Jun;27(3):209–18. doi: 10.1097/00004703-200606000-00006. PMID: 16775518. IncludeDE_KQ1 Record ID 24677 [PubMed: 16775518] [CrossRef]

490.

Tris Pharma I. TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD). 2014. IncludeDE_KQ2 Record ID 13784

491.

Tutty S, Gephart H, Wurzbacher K. Enhancing behavioral and social skill functioning in children newly diagnosed with attention-deficit hyperactivity disorder in a pediatric setting. J Dev Behav Pediatr. 2003 Feb;24(1):51–7. doi: 10.1097/00004703-200302000-00010. PMID: 12584485. IncludeDE_KQ2 Record ID 27367 [PubMed: 12584485] [CrossRef]

492.

Tzang RF, Chang YC, Tsai GE, et al. Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children. J Psychopharmacol. 2016 Oct;30(10):976–82. doi: 10.1177/0269881116658986. PMID: 27443598. IncludeDE_KQ2 Record ID 13495 [PubMed: 27443598] [CrossRef]

493.

Uyulan C, Erguzel TT, Turk O, et al. A Class Activation Map-Based Interpretable Transfer Learning Model for Automated Detection of ADHD from fMRI Data. Clin EEG Neurosci. 2023 Mar;54(2):151–9. doi: 10.1177/15500594221122699. PMID: 36052402. IncludeDE_KQ1 Record ID 26699 [PubMed: 36052402] [CrossRef]

494.

Vahid A, Bluschke A, Roessner V, et al. Deep Learning Based on Event-Related EEG Differentiates Children with ADHD from Healthy Controls. J Clin Med. 2019 Jul 19;8(7). doi: 10.3390/jcm8071055. PMID: 31330961. IncludeDE_KQ1 Record ID 3311 [PMC free article: PMC6679086] [PubMed: 31330961] [CrossRef]

495.

Vaidyanathan S, Chandrasekaran V, Kandasamy P. Comparison of brief group behavioural parent training with individual parent training for preschool children with attention deficit hyperactivity disorder: A randomized feasibility study. Early Interv Psychiatry. 2023 Apr 11. doi: 10.1111/eip.13420. PMID: 37041696. IncludeDE_KQ2 Record ID 28425 [PubMed: 37041696] [CrossRef]

496.

Valero M, Cebolla A, Colomer C. Mindfulness Training for Children with ADHD and Their Parents: A Randomized Control Trial. J Atten Disord. 2021 Jun 30:10870547211027636. doi: 10.1177/10870547211027636. PMID: 34189992. IncludeDE_KQ2 Record ID 3676 [PubMed: 34189992] [CrossRef]

497.

van der Donk M, Hiemstra-Beernink AC, Tjeenk-Kalff A, et al. Cognitive training for children with ADHD: a randomized controlled trial of cogmed working memory training and ‘paying attention in class’. Front Psychol. 2015;6:1081. doi: 10.3389/fpsyg.2015.01081. PMID: 26284005. IncludeDE_KQ2 Record ID 15595 [PMC free article: PMC4516808] [PubMed: 26284005] [CrossRef]

498.

Van der Heijden KB, Smits MG, Van Someren EJ, et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry. 2007 Feb;46(2):233–41. doi: 10.1097/01.chi.0000246055.76167.0d. PMID: 17242627. IncludeDE_KQ2 Record ID 24345 [PubMed: 17242627] [CrossRef]

499.

van der Oord S, Prins PJ, Oosterlaan J, et al. Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD? Eur Child Adolesc Psychiatry. 2007 Feb;16(1):48–57. doi: 10.1007/s00787-006-0574-z. PMID: 16972117. IncludeDE_KQ2 Record ID 27368 [PubMed: 16972117] [CrossRef]

500.

van Stralen JPM. A Controlled Trial of Extended-Release Guanfacine and Psychostimulants on Executive Function and ADHD. J Atten Disord. 2020 Jan;24(2):318–25. doi: 10.1177/1087054717751197. PMID: 29313415. IncludeDE_KQ2 Record ID 335 [PubMed: 29313415] [CrossRef]

501.

Varela Casal P, Lorena Esposito F, Morata Martínez I, et al. Clinical Validation of Eye Vergence as an Objective Marker for Diagnosis of ADHD in Children. J Atten Disord. 2019 Apr;23(6):599–614. doi: 10.1177/1087054717749931. PMID: 29357741. IncludeDE_KQ1 Record ID 779 [PubMed: 29357741] [CrossRef]

502.

Vogt C, Shameli A. Assessments for attention-deficit hyperactivity disorder: Use of objective measurements. The Psychiatrist. 2011;35(10):380–3. doi: 10.1192/pb.bp.110.032144. IncludeDE_KQ1 Record ID 27289 [CrossRef]

503.

Voigt RG, Llorente AM, Jensen CL, et al. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr. 2001 Aug;139(2):189–96. doi: 10.1067/mpd.2001.116050. PMID: 11487742. IncludeDE_KQ2 Record ID 27223 [PubMed: 11487742] [CrossRef]

504.

Volpe RJ DG, Jitendra AK, et al. Consultation-based academic interventions for children with attention deficit hyperactivity disorder: effects on reading and mathematics outcomes at 1-year follow-up. School Psych Rev. 2009;38(1):5–13. IncludeDE_KQ2 Record ID 18313

505.

Wang LJ, Li SC, Lee MJ, et al. Blood-bourne microRNA biomarker evaluation in attention-deficit/hyperactivity disorder of han chinese individuals: An exploratory study. Frontiers in Psychiatry. 2018;9(MAY). doi: 10.3389/fpsyt.2018.00227. IncludeDE_KQ1 Record ID 9992 [CrossRef]

506.

Wang Y, Zheng Y, Du Y, et al. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Aust N Z J Psychiatry. 2007 Mar;41(3):222–30. doi: 10.1080/00048670601057767. PMID: 17464703. IncludeDE_KQ2 Record ID 17513 [PubMed: 17464703] [CrossRef]

507.

Wassenberg R, Max JE, Koele SL, et al. Classifying psychiatric disorders after traumatic brain injury and orthopaedic injury in children: adequacy of K-SADS versus CBCL. Brain Inj. 2004 Apr;18(4):377–90. doi: 10.1080/02699050310001617325. PMID: 14742151. IncludeDE_KQ1 Record ID 23728 [PubMed: 14742151] [CrossRef]

508.

Weber W, Vander Stoep A, McCarty RL, et al. Hypericum perforatum (St John’s wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. Jama. 2008 Jun 11;299(22):2633–41. doi: 10.1001/jama.299.22.2633. PMID: 18544723. IncludeDE_KQ2 Record ID 17429 [PMC free article: PMC2587403] [PubMed: 18544723] [CrossRef]

509.

Webster RE. Attending Patterns of ADHD Children on the Learning Efficiency Test-II. 2000. IncludeDE_KQ1 Record ID 16583

510.

Wehmeier PM, Schacht A, Ulberstad F, et al. Does atomoxetine improve executive function, inhibitory control, and hyperactivity? Results from a placebo-controlled trial using quantitative measurement technology. J Clin Psychopharmacol. 2012 Oct;32(5):653–60. doi: 10.1097/JCP.0b013e318267c304. PMID: 22926599. IncludeDE_KQ2 Record ID 19288 [PubMed: 22926599] [CrossRef]

511.

Weisman O, Schonherz Y, Harel T, et al. Testing the Efficacy of a Smartphone Application in Improving Medication Adherence, Among Children with ADHD. Isr J Psychiatry Relat Sci. 2018;55(2):59–63. PMID: 30368489. IncludeDE_KQ3 Record ID 406 [PubMed: 30368489]

512.

Weiss M, Hechtman L, Turgay A, et al. Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007 Oct;17(5):675–88. doi: 10.1089/cap.2006.0101. PMID: 17979587. IncludeDE_KQ2 Record ID 17511 [PubMed: 17979587] [CrossRef]

513.

Weiss M, Tannock R, Kratochvil C, et al. A Randomized, Placebo-Controlled Study of Once-Daily Atomoxetine in the School Setting in Children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2005 07/01/;44(7):647–55. doi: 10.1097/01.chi.0000163280.47221.c9. PMID: 15968233. IncludeDE_KQ2 Record ID 18388 [PubMed: 15968233] [CrossRef]

514.

Weiss MD, Cutler AJ, Kollins SH, et al. Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension. J Child Adolesc Psychopharmacol. 2021 Nov;31(9):610–22. doi: 10.1089/cap.2021.0034. PMID: 34637343. IncludeDE_KQ2 Record ID 13544 [PubMed: 34637343] [CrossRef]

515.

Wennberg B, Janeslätt G, Kjellberg A, et al. Effectiveness of time-related interventions in children with ADHD aged 9-15 years: a randomized controlled study. Eur Child Adolesc Psychiatry. 2018 Mar;27(3):329–42. doi: 10.1007/s00787-017-1052-5. PMID: 28956183. IncludeDE_KQ2 Record ID 399 [PMC free article: PMC5852175] [PubMed: 28956183] [CrossRef]

516.

Westerberg H, Hirvikoski T, Forssberg H, et al. Visuo-spatial working memory span: a sensitive measure of cognitive deficits in children with ADHD. Child Neuropsychol. 2004 Sep;10(3):155–61. doi: 10.1080/09297040409609806. PMID: 15590494. IncludeDE_KQ1 Record ID 23741 [PubMed: 15590494] [CrossRef]

517.

Weyandt LL, Willis WG. Executive functions in school-aged children: Potential efficacy of tasks in discriminating clinical groups. Developmental Neuropsychology. 1994 1994/01/01;10(1):27–38. doi: 10.1080/87565649409540564. IncludeDE_KQ1 Record ID 24621 [CrossRef]

518.

Wietecha LA, Williams DW, Herbert M, et al. Atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Dec;19(6):719–30. doi: 10.1089/cap.2008.074. PMID: 20035590. IncludeDE_KQ2 Record ID 14640 [PubMed: 20035590] [CrossRef]

519.

Wigal S, Swanson JM, Feifel D, et al. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1406–14. doi: 10.1097/01.chi.0000138351.98604.92. PMID: 15502600. IncludeDE_KQ2 Record ID 15041 [PubMed: 15502600] [CrossRef]

520.

Wigal SB, Wigal T, Schuck S, et al. Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Apr;21(2):121–31. doi: 10.1089/cap.2010.0047. PMID: 21488750. IncludeDE_KQ2 Record ID 17070 [PMC free article: PMC3080768] [PubMed: 21488750] [CrossRef]

521.

Wilens TE, Boellner SW, López FA, et al. Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):700–8. doi: 10.1097/CHI.0b013e31816bffdf. PMID: 18434918. IncludeDE_KQ2 Record ID 17426 [PubMed: 18434918] [CrossRef]

522.

Wilens TE, Gault LM, Childress A, et al. Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials. J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):73–84.e1. doi: 10.1016/j.jaac.2010.10.001. PMID: 21156272. IncludeDE_KQ2 Record ID 15087 [PMC free article: PMC3757954] [PubMed: 21156272] [CrossRef]

523.

Wilens TE, Spencer TJ, Biederman J. Short- and long-term cardiovascular effects of mixed amphetamine salts extended-release in adolescents with ADHD. CNS Spectrums. 2005;10(10 SUPPL. 15):22–30. doi: 10.1017/s1092852900014115. IncludeDE_KQ2 Record ID 16448 [PubMed: 16273027] [CrossRef]

524.

Wilens TE BO, Brams M, Cutler AJ, Childress A, Rugino T, Lyne A, Grannis K, Youcha S. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):74–85.e2. doi: 10.1016/j.jaac.2011.10.012. PMID: 22176941. IncludeDE_KQ2 Record ID 19257 [PubMed: 22176941] [CrossRef]

525.

Wilens TE RB, Sikirica V, Harper L, Young JL, Bloomfield R, Lyne A, Rynkowski G, Cutler AJ. A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):916–25.e2. doi: 10.1016/j.jaac.2015.08.016. PMID: 26506582. IncludeDE_KQ2 Record ID 19233 [PubMed: 26506582] [CrossRef]

526.

Wilkes-Gillan S, Bundy A, Cordier R, et al. A Randomised Controlled Trial of a Play-Based Intervention to Improve the Social Play Skills of Children with Attention Deficit Hyperactivity Disorder (ADHD). PLoS One. 2016;11(8):e0160558. doi: 10.1371/journal.pone.0160558. PMID: 27529693. IncludeDE_KQ2 Record ID 13725 [PMC free article: PMC4987013] [PubMed: 27529693] [CrossRef]

527.

Williams LM, Hermens DF, Thein T, et al. Using Brain-Based Cognitive Measures to Support Clinical Decisions in ADHD. Pediatric Neurology. 2010 2010/02/01/;42(2):118–26. doi: 10.1016/j.pediatrneurol.2009.08.010. PMID: 20117748. IncludeDE_KQ1 Record ID 11 [PubMed: 20117748] [CrossRef]

528.

Wodka EL, Loftis C, Mostofsky SH, et al. Prediction of ADHD in boys and girls using the D-KEFS. Arch Clin Neuropsychol. 2008 May;23(3):283–93. doi: 10.1016/j.acn.2007.12.004. PMID: 18243646. IncludeDE_KQ1 Record ID 24469 [PMC free article: PMC2427435] [PubMed: 18243646] [CrossRef]

529.

Wolraich ML, Greenhill LL, Pelham W, et al. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics. 2001 Oct;108(4):883–92. doi: 10.1542/peds.108.4.883. PMID: 11581440. IncludeDE_KQ2 Record ID 15145 [PubMed: 11581440] [CrossRef]

530.

Wood AC, Asherson P, Rijsdijk F, et al. Is overactivity a core feature in ADHD? Familial and receiver operating characteristic curve analysis of mechanically assessed activity level. J Am Acad Child Adolesc Psychiatry. 2009 Oct;48(10):1023–30. doi: 10.1097/CHI.0b013e3181b54612. PMID: 19701105. IncludeDE_KQ1 Record ID 27434 [PubMed: 19701105] [CrossRef]

531.

Wu Y, Xu L, Wu Z, et al. Computer-based multiple component cognitive training in children with ADHD: a pilot study. Child and Adolescent Psychiatry and Mental Health. 2023;17(1). doi: 10.1186/s13034-022-00553-z. IncludeDE_KQ2 Record ID 25569 [CrossRef]

532.

Yang J, Yoon BM, Lee MS, et al. Adherence with electronic monitoring and symptoms in children with attention deficit hyperactivity disorder. Psychiatry Investigation. 2012;9(3):263–8. doi: 10.4306/pi.2012.9.3.263. IncludeDE_KQ3 Record ID 16169 [PMC free article: PMC3440476] [PubMed: 22993526] [CrossRef]

533.

Yao D, Guo X, Zhao Q, et al. Discriminating ADHD From Healthy Controls Using a Novel Feature Selection Method Based on Relative Importance and Ensemble Learning. Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:4632–5. doi: 10.1109/embc.2018.8513155. PMID: 30441383. IncludeDE_KQ1 Record ID 1413 [PubMed: 30441383] [CrossRef]

534.

Yasumura A, Omori M, Fukuda A, et al. Applied Machine Learning Method to Predict Children With ADHD Using Prefrontal Cortex Activity: A Multicenter Study in Japan. J Atten Disord. 2020 Dec;24(14):2012–20. doi: 10.1177/1087054717740632. PMID: 29154696. IncludeDE_KQ1 Record ID 1714 [PubMed: 29154696] [CrossRef]

535.

Yeh SC, Lin SY, Wu EH, et al. A Virtual-Reality System Integrated With Neuro-Behavior Sensing for Attention-Deficit/Hyperactivity Disorder Intelligent Assessment. IEEE Trans Neural Syst Rehabil Eng. 2020 Sep;28(9):1899–907. doi: 10.1109/tnsre.2020.3004545. PMID: 32746303. IncludeDE_KQ1 Record ID 1831 [PubMed: 32746303] [CrossRef]

536.

Yoo JH, Kim JI, Kim BN, et al. Exploring characteristic features of attention-deficit/hyperactivity disorder: findings from multi-modal MRI and candidate genetic data. Brain Imaging Behav. 2020 Dec;14(6):2132–47. doi: 10.1007/s11682-019-00164-x. PMID: 31321662. IncludeDE_KQ1 Record ID 1504 [PubMed: 31321662] [CrossRef]

537.

Young J, Rugino T, Dammerman R, et al. Efficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners’ Parent Rating Scale-revised: Short Form. J Child Adolesc Psychopharmacol. 2014 Oct;24(8):435–41. doi: 10.1089/cap.2013.0134. PMID: 25286026. IncludeDE_KQ2 Record ID 15140 [PMC free article: PMC4203148] [PubMed: 25286026] [CrossRef]

538.

Zadehbagheri F, Hosseini E, Bagheri-Hosseinabadi Z, et al. Profiling of miRNAs in serum of children with attention-deficit hyperactivity disorder shows significant alterations. J Psychiatr Res. 2019 Feb;109:185–92. doi: 10.1016/j.jpsychires.2018.12.013. PMID: 30557705. IncludeDE_KQ1 Record ID 2204 [PubMed: 30557705] [CrossRef]

539.

Zarinara AR, Mohammadi MR, Hazrati N, et al. Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Hum Psychopharmacol. 2010 Nov;25(7–8):530–5. doi: 10.1002/hup.1148. PMID: 20860068. IncludeDE_KQ2 Record ID 17194 [PubMed: 20860068] [CrossRef]

540.

Zavadenko NN, Suvorinova NY, Vakula IN, et al. Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Children: Results of a Multicenter, Double-Blind, Placebo-Controlled Trial of Hopantenic Acid. Neuroscience and Behavioral Physiology. 2019;49(1):129–35. doi: 10.1007/s11055-018-0705-2. IncludeDE_KQ2 Record ID 10183 [CrossRef]

541.

Zelko FA. Comparison of parent-completed behavior rating scales: differentiating boys with ADD from psychiatric and normal controls. J Dev Behav Pediatr. 1991 Feb;12(1):31–7. PMID: 2016400. IncludeDE_KQ1 Record ID 24678 [PubMed: 2016400]

542.

Zelnik N B-BO, Miari W, et al. Is the test of variables of attention reliable for the diagnosis of attention-deficit hyperactivity disorder (ADHD)? J Child Neurol. 2012 Jun;27(6):703–7. doi: 10.1177/0883073811423821. PMID: 22378668. IncludeDE_KQ1 Record ID 17013 [PubMed: 22378668] [CrossRef]

543.

Zheng X, Shen L, Jiang L, et al. Parent and Teacher Training Increases Medication Adherence for Primary School Children With Attention-Deficit/Hyperactivity Disorder. Front Pediatr. 2020;8:486353. doi: 10.3389/fped.2020.486353. PMID: 33240827. IncludeDE_KQ2 Record ID 3326 [PMC free article: PMC7680838] [PubMed: 33240827] [CrossRef]

544.

Zhou D, Liao Z, Chen R. Deep Learning Enabled Diagnosis of Children’s ADHD Based on the Big Data of Video Screen Long-Range EEG. J Healthc Eng. 2022;2022:5222136. doi: 10.1155/2022/5222136. PMID: 35419186. IncludeDE_KQ1 Record ID 26811 [PMC free article: PMC9001066] [PubMed: 35419186] [CrossRef]

545.

Zhou X, Reynolds CR, Zhu J, et al. Evidence-based assessment of ADHD diagnosis in children and adolescents. Appl Neuropsychol Child. 2018 Apr–Jun;7(2):150–6. doi: 10.1080/21622965.2017.1284661. PMID: 28631964. IncludeDE_KQ1 Record ID 675 [PubMed: 28631964] [CrossRef]

546.

Zhu C. Effects of Musicotherapy Combined with Cognitive Behavioral Intervention on the Cognitive Ability of Children with Attention Deficit Hyperactivity Disorder. Psychiatr Danub. 2022 Summer;34(2):288–95. doi: 10.24869/psyd.2022.288. PMID: 35772139. IncludeDE_KQ2 Record ID 26814 [PubMed: 35772139] [CrossRef]

547.

Zhu P, Pan J, Cai QQ, et al. MicroRNA profile as potential molecular signature for attention deficit hyperactivity disorder in children. Biomarkers. 2022 May;27(3):230–9. doi: 10.1080/1354750x.2021.2024600. PMID: 34989306. IncludeDE_KQ1 Record ID 26815 [PubMed: 34989306] [CrossRef]

548.

Zhu X, Sun X, Zhang Y, et al. A randomized parallel-controlled study of curative effect and safety of atomoxetine and methylphenidate in treatment of ADHD in children. International Journal of Clinical and Experimental Medicine. 2017;10(6):9576–82. IncludeDE_KQ2 Record ID 10208

549.

Zhuo L, Zhao X, Zhai Y, et al. Transcutaneous electrical acupoint stimulation for children with attention-deficit/hyperactivity disorder: a randomized clinical trial. Transl Psychiatry. 2022 Apr 21;12(1):165. doi: 10.1038/s41398-022-01914-0. PMID: 35449191. IncludeDE_KQ2 Record ID 26817 [PMC free article: PMC9022403] [PubMed: 35449191] [CrossRef]

550.

Zulueta A, Díaz-Orueta U, Crespo-Eguilaz N, et al. Virtual reality-based assessment and rating scales in ADHD diagnosis. Psicología Educativa. 2019 2019;25(1):13–22. IncludeDE_KQ1 Record ID 12686